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ABSTRACT 
 
 Early or two-phase orthodontic treatment of Class II malocclusions is a 
debated topic in orthodontic circles primarily because the benefits of early 
intervention have not been consistently reproduced among researchers.  The 
present study was a retrospective analysis of cephalograms from patients with 
Class II, division 1 malocclusions at the start of treatment.  These were 50 
consecutively treated youths who received phase 1 (early) treatment with a 
Bionator appliance and later treatment with full appliances (all treated by a 
single clinician).  The comparison group consisted subjects treated in a single 
phase with fixed Edgewise appliances only.  Importantly, subjects in the two 
samples were matched, on a one-to-one basis, for demographic and 
cephalometric variables (ANB, SNA, SNB, NAP, FMA) to ensure comparability 
in the nature and severity of the malocclusions.  The key question was whether 
the cephalometric results at the end of treatment were comparable between 
groups.  Two-phase subjects were treated on average 1.4 years longer than the 
one-phase group, though this measure of clock time may obscure the greater 
ease of treatment chair side.  Neither of out two integumental variables (Z 
angle, E plane) differed statistically, but two key skeletal variables did differ, 
namely ANB and NAP.  ANB was significantly smaller ( x  = 2.6°) in the two-
phase group than in the one-phase group ( x  = 3.7°), and NAP averaged 2.7º in 
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the two-phase group compared to a mean of 4.8º in the one-phase group.  
Consequently, the two-phase group was discernibly more orthognathic at the 
end of treatment, with most of the correction coming from mandibular growth 
rather than maxillary restriction.  None of the dental variables differed 
statistically except the position of the maxillary incisors which were slightly 
more proclined in the two-phase group, and this was due to operator 
preference.  The two-phase subjects had a lower rate of premolar extraction 
(12% vs 84%) than the one-phase subjects.  Overall, the two-phase group 
achieved a better bony facial profile, with the majority of the skeletal and 
dental correction occurring during the first phase of treatment.  These favorable 
results contrast with published randomized clinical trials, possibly because of 
differences in patient selection and appliance design.  Our results do support 
the value of early intervention, though it is not known whether the statistically 
significant improvements in the facial profile are large enough to be perceptible 
to the patient and parents. 
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CHAPTER I 
INTRODUCTION 
 
Class II malocclusions are a prevalent type of skeletodental disharmony.  
Not only is the correction of these malocclusions challenging to the specialist, 
but the underlying etiological factors that produce the malocclusion are both 
variable and poorly understood.  Insufficient mandibular growth rather than 
maxillary excess is a common issue with Class II malocclusions.  One 
traditional form of fixed orthodontic treatment is extra-oral anchorage coupled 
with full appliances to retain maxillary position in the anticipation of favorable 
mandibular growth. 
An alternative to conventional treatment in the early permanent 
dentition is the use of functional appliances in early or so-called phase 1 
treatment in the mixed dentition.  Functional appliances have been employed 
to promote the correction of skeletal Class II malocclusions by propulsing the 
mandible into a more desirable position to “encourage” mandibular growth 
and dental correction.  True to its name, the intended goal of a functional 
appliance is to alter the functional environment in order to alter the form of the 
surrounding structures. 
Since its introduction in the early 1960s, the Bionator has been a popular 
functional appliance for the early treatment of Class II malocclusions (Graber 
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2005).  The treatment value of functional appliances has been a topic of debate, 
and there has been considerable discussion in the orthodontic literature 
regarding the biological and clinical advantages and disadvantages of early 
orthodontic treatment.  Some have argued that early treatment has no long-
term advantage (Tulloch et al. 2004).  Others argue that early treatment may 
reduce treatment time and reduce the complexity of the second phase of 
treatment (Dugoni 1998).  Reported benefits of early treatment include the 
ability to intercept and/or reduce dentoalveolar, skeletal, and muscular 
abnormalities prior to the eruption of the permanent dentition (McNamara and 
Brudon 1998).  Moyers (1998) suggests that early treatment of Class II 
malocclusions may harness normal growth to gain skeletal correction before 
the malocclusion becomes more severe, and he notes that there often is greater 
compliance in younger patients. 
Other reported benefits include:  reduced need for extraction, better 
treatment results, less potential for damage such as tooth fracture prior to 
treatment, and improved patient self esteem (Bishara et al. 1998).  Opponents of 
two-phase treatment in Class II malocclusions contend that early treatment 
produces no reduction in the average time a child is in fixed appliances nor 
does it reduce the proportion of complex treatments involving extractions or 
orthognathic surgery (Tulloch et al. 2004). 
 2 
In cases of Class II malocclusions due to mandibular deficiencies, 
functional appliances often are used with the intent of stimulating mandibular 
growth.  The notion that functional appliances can enhance mandibular growth 
has been controversial.  Björk (1951) and Nelson et al. (1993) concluded that 
functional appliances contribute little to final mandibular size.  In contrast, 
authors such as Bolmgreen and Mishiri (1986), Mills (1991), Ghafari and 
coworkers, (1998), and Illing et al. (1998) conclude that the use of functional 
appliances significantly enhances mandibular growth.  Other research indicates 
that the treatment effects of functional appliances are restricted to 
dentoalveolar compensations (Chadwick et al. 2001). 
Of principal concern is the benefit of early Class II treatment in the 
mixed dentition compared with treatment started in the early permanent 
dentition.  What is gained with regards to treatment outcomes with a two-
phase treatment protocol compared to one-phase?  A recent study on this 
question concluded that there is no difference between subjects treated in two 
phases compared to those treated in a single phase (Tulloch et al. 2004). 
In a randomized clinical trial subjects are not allocated according to who 
would respond favorably to a certain treatment modality based on clinical 
evaluation; rather, they are randomly assigned to the treatment protocols.  
Although allocation bias is curtailed, the ability to choose treatment modalities 
based on clinical evaluation also is eliminated.  Subjects who may respond 
 3 
favorably to early treatment may not be assigned to the treatment modality 
best suited to them. 
The purpose of the present study is to gain substantive information 
through the analysis of cephalometric radiographs about the consequences of 
the Bionator during early treatment.  Orthodontic cases were studied in which 
treatment was used coupled with subsequent fixed appliance treatment.  By 
comparing the outcome of these cases to a matched group of cases treated with 
only fixed appliances in the early permanent dentition, the intent is to assess 
the relevant skeletodental benefits, if any, of the extra effort involved in two-
phase treatment. 
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CHAPTER II 
REVIEW OF THE LITERATURE 
 
The use of removable appliances for the treatment of skeletodental 
discrepancies has been reported as early as the late nineteenth century.  The 
term “functional jaw orthopedics” was originally employed to describe the 
form of treatment where these appliances were used to alter the patient’s 
functional environment in hopes of improved dental and skeletal correction 
(Graber and Neumann 1984). 
 
Removable Orthodontic Appliances 
Norman Kingsley in 1879 described a bite plate to change or “jump” the 
bite in patients who exhibited excessive overjet and retrognathic mandibles.  
The term “jumping the bite” originally described the concept of getting the 
mandible to “jump” into a favorable occlusal position and inducing it to stay 
there.  This treatment was often utilized after expansion of the arches, but often 
did not prove successful due to the mandible’s tendency to revert to its original 
position.  In 1902 Pierre Robin described the monobloc appliance that he used 
for bimaxillary expansion.  Watry (1910) later coupled use of the monobloc 
with muscular exercises for what he termed “functional reeducation.”  This 
would be a precursor to the activator appliance, but differed by having the 
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mandible postured forward by the patient’s voluntary muscle action only.  
Rogers (1918) recognized the influence of the facial musculature on orthodontic 
treatment and recommended exercises to develop these muscles.  He was one 
of the first to emphasize the importance of the musculature on the growth and 
development of the oral environment.  In 1908 Andresen made an appliance for 
his daughter meant for retention and to prevent mouth breathing.  The device 
entailed a bite plate with extensions to cover the lingual surfaces of the 
mandibular teeth.  After seeing the favorable results obtained on his daughter, 
Andresen recognized the potential of the new appliance.  The development of 
the activator proved to be a milestone in the history of orthodontics and was a 
forerunner to the development of many other functional appliances (Graber 
and Neumann 1984). 
 
Development of the Bionator 
The Bionator is an activator-derived device that was introduced  by 
Balters (1893–1973) in the early 1960s.  Balters’ treatment was holistic; the 
Bionator was used in conjunction with postural exercises, gymnastics, and 
dietary control.  Balters’ objective in treatment was to establish a muscular 
equilibrium between the tongue and the “outer neuromuscular envelope” 
(Eirew 1981).  According to Balters, the equilibrium between the tongue and 
cheeks is paramount in the normal development of the dentition and of the 
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dental arches, and providing the tongue with adequate functional space is of 
utmost importance (Graber and Neumann 1984).  In Balters’ perception, Class 
II malocclusions are a result of a backward (dorsal) position of the tongue that 
disturbs the cervical region and impedes respiratory function, causing faulty 
swallowing patterns and mouth breathing.  Therefore, one of the main 
objectives of treatment in Class II division 1 malocclusions is to bring the 
tongue forward.  In turn, continuously posturing the mandible forward also 
enlarges the respiratory pathways and enhances deglutition (Graber and 
Neumann 1984).  According to Balters, the essential points for treatment are (1) 
to accomplish lip closure and bring the tongue back into contact with the soft 
palate, (2) to enlarge the oral space and to train its function, (3) to bring the 
incisors into an edge to edge relationship, (4) to elongate the mandible that will 
enlarge the oral space, and (5) to achieve an improved relationship of the jaws, 
tongue and dentition, as well as the surrounding soft tissues (Graber and 
Neumann 1984).  The Bionator is indicated in the treatment of Class II, division 
1 malocclusions when (1) the dental arches are originally well aligned, (2) the 
mandible is in a posterior position, (3) the skeletal discrepancy is not too 
severe, and (4) there is  labial tipping of the upper incisor crowns (Eirew 1981). 
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Functional Appliances and Mandibular Growth 
Enhanced mandibular growth with the use of functional appliances has 
been reported by many authors, but whether these findings indicate a true 
overall increase in mandibular length is a topic of debate.  Functional 
protrusive appliances have been employed in laboratory animals to assess 
mandibular growth vectors and temporomandibular joint changes due to 
continued forward posturing.  Oudet and others (1984) investigated the effects 
of a functional protrusive appliance on mandibular growth in rats.  After 4 
weeks of treatment, the experimental group showed an accelerated growth rate 
of the condylar cartilage, and the direction of growth became more backward 
oriented.  McNamara et al. (1987) evaluated mandibular changes in rhesus 
monkeys that were fit with an adapted functional appliance.  Cephalometric 
analysis of the 11 treated monkeys compared to controls (n = 12) revealed 
mandibular length increases of 5 to 6 mm over the 14 weeks of the experiment.  
Sampson et al. (2001) evaluated changes in mandibular condylar growth in 
sheep fitted with an experimental functional appliance.  Four, 4-month old 
male sheep were fitted with the adapted appliance and were evaluated 15 
weeks later.  Fluorescence microscopy performed after sectioning of the 
temporomandibular joint revealed a range of 8.5 to 13.3 mm of condylar 
growth, with a mean of 11.4 mm.  The sheep in the control group exhibited a 
range of 8.8 to 11.9 mm of condylar growth with a mean of 10.6 mm.  Rabie et 
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al. (2003) reported an increase in the concentration of Sox 9 (a regulator of 
chondrocyte differentiation) in a study involving 5-week-old female rats 
wearing adapted functional protrusive appliances. 
 
Condylar Cartilage and Mandibular Growth 
Correction of mandibular retrognathia by increased condylar growth 
due to hyperpropulsion of the mandible has been investigated.  Studies vary in 
the manner in which the mandible was anteriorly positioned; some appliances 
were removable, while others were fixed.  The histological composition of the 
temporomandibular joint has been shown, both in laboratory and clinical 
studies, to be susceptible to local extrinsic factors.   
Condylar cartilage of the mandible is unique in several respects.  
Whereas the primary effectors of growth of the epiphyseal cartilages of long 
bones, nasal cartilage, and cranial base synchondroses are growth hormone 
and somatomedin, condylar cartilage is to a great degree regulated by extrinsic 
local factors (particularly tension of the lateral pterygoid muscle), as well as 
growth hormone (Petrovic et al. 1974; Koski 1977).  Structurally, condylar 
cartilage consists of three basic zones.  The articular zone is fibrous connective 
tissue and is located at the most superior aspect of the condyle.  Internal to the 
connective tissue layer is the proliferative zone where appositional growth 
occurs by differentiation of mesenchymal cells into prechondroblasts, 
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chondroblasts, and chondrocytes.  The third, deepest zone is the hypertrophic 
zone, where chondrocytes are enlarged and bone formation occurs (Durkin 
1972; McNamara et al. 1975). 
Any type of appliance that causes chronic contraction of the lateral 
pterygoid muscle, reduction of the serial sacromeres, and, thus, actual 
shortening of the muscle has been shown by Petrovic (1975) to induce cellular 
proliferation in the prechondroblastic zone of the condylar cartilage.  The 
“servosystem” theory is valuable here by way of interpretation (Petrovic et al. 
1981).  Petrovic and coworkers stated that the maxilla, in normal function, is 
under considerable genetic control and is a constantly changing reference point 
that the mandible must occlude with and react to.  The optimal occlusal and 
cuspal relationship is a Class I molar relationship, whereas Class II and Class 
III relationships fall short of this.  However, so long as a given occlusal 
relationship is not interrupted, skeletal and dental growth continues.  
Introduction of an appliance interrupts the occlusal relationship, and, 
consequently, initiates a postural response.  The lateral pterygoid contracts, 
and protrudes the mandible in search of a comfortable intercuspal relationship 
from which dentoskeletal growth can continue.  This action of the lateral 
pterygoid appears to be a prime cause of condylar cartilage proliferation where 
chronic protrusion induces endochondral bone growth (Petrovic et al. 1975).  It 
is generally understood that the condyle is not a “pacemaker” for growth of the 
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mandible.  Instead, it possesses a capacity for growth and remodeling in 
selective response to varied mandibular displacement and rotation.  Very 
simply, it provides regional adaptive growth (Enlow 1968). 
Numerous studies have investigated the temporomandibular joint’s 
response to functional appliance therapy, principally focusing on the condyle 
and glenoid fossa.  Charlier and Petrovic (1969) described changes in the 
amount and rate of condylar cartilage growth in rats after mandibular 
hyperpropulsion.  Stöckli and Willert (1973) performed a histological study of 
adaptations in the temporomandibular joint during induced protrusive 
function in monkeys.  These authors suggested that the adaptive tissue changes 
seen in the temporomandibular joint could be induced by mechanical stimuli, 
and that these changes were resistant to relapse after the removal of the 
appliances.  McNamara (1975), in a histological evaluation involving rhesus 
monkeys fitted with appliances to induce protrusive function, reported similar 
findings and identified the age of the subject as a principal factor for response 
to function alterations.  He stated that, “a stimulus which may lead to adaptive 
changes at one particular time may be ineffective at a later stage of 
development “ (McNamara 1975:133).  Zhao et al. (1999) reported new bone 
formation through analysis of histological sections from the posterior aspect of 
the glenoid fossa in rats fitted with a bite-jumping appliance.  Ruf and 
Pancherz (1999) examined magnetic resonance images of the 
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temporomandibular joint of 25 adolescent and 14 young adult patients treated 
with the Herbst appliance for treatment of Class II malocclusions.  In all of the 
adolescents, condylar remodeling occurred in the posterior aspect as well as 
remodeling in the posterior aspect of the glenoid fossa.  In contrast, Katsavrias 
(2003) studied lateral tomograms of 35 patients (18 boys, 17 girls) treated with 
activator appliances and found no posttreatment changes in any portion of the 
articular eminence. 
 
Treatment Effects Produced by the Bionator Appliance 
Treatment effects produced by the Bionator appliance can be divided 
into two types, namely the effects on dentoalveolar development and the 
effects on skeletal development.  Janson (1977) evaluated 134 patients treated 
with the Bionator for 12 to 18 months, and compared them to 73 untreated 
individuals.  Each individual presented with a Class II malocclusion.  Lateral 
cephalometric radiographs and hand-wrist films were taken at the start and 
end of treatment.  Treatment was deemed complete when a Class I molar 
relationship was achieved along with an average of 2 mm of overjet.  Skeletal 
maturity was assessed for both time points using hand-wrist films, and 14 
cephalometric variables were used to evaluate the dentoalveolar and skeletal 
changes.  Both dentoalveolar and skeletal changes occurred in the treatment 
group, but the dentoalveolar changes were greater as shown by an increase in 
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protrusion of the lower incisors and retrusion of the upper incisors.  Although 
there were marked skeletal changes in some individuals in the treatment 
group, especially those who began treatment just prior to the pubertal growth 
spurt, the authors found no significant difference between the two groups 
regarding the skeletal measurements.  They ascertained that the Class II to 
Class I correction was achieved mostly through dentoalveolar adaptation in 
combination with a reduction in ANB through the natural pattern of 
mandibular growth. 
Janson (1987) conducted another study using the same sample of 134 
patients treated only with the Bionator.  Of the 134 patients, 99 required fixed 
orthodontic appliances after Bionator therapy while the other 35 individuals 
showed a stable Class I occlusion with adequate alignment of the teeth 
following Bionator therapy alone.  Five years after treatment, 28 of the 35 
patients treated with the Bionator alone were compared to 31 of the 99 patients 
who underwent Bionator therapy and later fixed appliances.  All patients were 
treated nonextraction to a Class I molar relationship.  Full orthodontic records 
were taken on each patient, and cephalometric data were compared at four 
different time points:  (1) at the start of treatment, (2) after the establishment of 
a Class I molar relationship, (3) at the completion of treatment with either the 
Bionator or fixed appliances, and (4) three to five years out of treatment.  The 
individuals treated only with the Bionator exhibited a greater mandibular 
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response as shown by an increase in mandibular length (Cd-Gn) and a 
subsequent reduction in ANB.  In the other group, the reduction in ANB was 
accomplished mainly through the restriction of maxillary growth. 
Bolmgren and Moshiri (1986) investigated the treatment effects of the 
Bionator on Class II division 1 patients in a cephalometric evaluation of 12 
males and 8 females who were selected for Bionator treatment.  The average 
age at the start of treatment was 11.8 years for the boys and 11.1 years for the 
girls.  The duration of the Bionator therapy ranged from 8 to 20 months with a 
mean interval of 12.7 months.  The second phase of treatment lasted on average 
of 15.9 months.  The control groups consisted of cephalometric data from 
untreated males and females of comparable ages as reported by Riolo et al. 
(1974), and patients treated with only fixed appliances with the cephalometric 
data obtained from the records of the Rocky Mountain Data Systems in 
California.  In the Bionator group, lateral cephalometric radiographs were 
taken at three time points:  (1) at the start of treatment, (2) after Bionator 
treatment, and (3) after fixed appliances.  The Bionator produced some 
maxillary incisor retraction and uprighting and protrusion of the lower 
incisors.  The mandibular plane was minimally increased.  There was an 
increase in mandibular length (Cd-Gn) of 5.0 mm in the Bionator group, 4.4 
mm in the fixed appliance group, and 2.5 mm in the untreated group.  There 
was a minor increase in anterior facial height in the Bionator group.  The 
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authors concluded that the orthodontic and orthopedic changes that occurred 
in the group treated with the Bionator and later fixed appliances were nearly 
identical to those that occurred in the group treated with fixed appliances 
alone. 
Heij and others (1989) evaluated the influence of variable degrees of 
protrusion built into the Bionator on treatment effects in a group of patients 
with Class II division 1 malocclusion.  Patients (n = 27) matched for age, sex, 
and type of malocclusion were divided into two groups based on the varying 
amounts of protrusion built into the construction bite used for the construction 
of the Bionator.  Group one consisted of six females and eight males with an 
average age of 10.3 years.  The Bionator for this group was fabricated using a 
construction bite taken with the incisors in an end-to-end position with 2 to 4 
mm of freeway space.  The patients were instructed to wear the Bionator 22 
hours per day.  Group 2 consisted of 7 females and 6 males with an average age 
of 10.3 years.  The Bionator for this group was fabricated from a construction 
bite with the maximum possible propulsion of the mandible in which the 
patient felt comfortable (usually the lower incisors were 2 mm in front of the 
upper incisors).  The patients wore the appliance 12 to 14 hours per day.  
Lateral cephalometric radiographs were taken on each patient before and after 
treatment.  As expected, in both groups there was a decrease in ANB and SNA 
angles along with a decrease in overjet and overbite.  An increase in the 
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amount of protrusion beyond edge to edge did not result in an increase in 
ramal growth.  However, an increase in protrusion past edge to edge did 
improve the mandibular sagittal relationship, possibly due to the downward 
displacement of the condyle.  The “headgear effect” was more pronounced in 
the edge-to-edge group.  The results suggested that changes in ramal height, 
condyle displacement, and the “headgear effect” seem to be related to the 
amount of protrusion built into the construction bite. 
Mammandras and Allen (1990) conducted a cephalometric analysis of 40 
Class II division 1 patients treated with the Bionator.  They were divided into 
two groups based on the horizontal change of Pogonion from pretreatment to 
posttreatment.  Group one deemed the “small advancement group” consisted 
of individuals with a mean age of 12.4 months and who exhibited 3 mm or less 
of anterior movement of skeletal Pogonion.  Group two, or the “large 
advancement group,” consisted of subjects with a mean age of 13.2 months 
exhibiting at least 3.5 mm of anterior movement of Pogonion.  Despite being 
slightly younger, the small advancement group exhibited mandibular 
dimensions that were similar or greater than the other group.  Compared to 
published growth standards (Michigan Growth Study), males in the large 
advancement group had mandibular lengths (Cd-Gn) that were significantly 
smaller.  The females exhibited this same trend.  The pretreatment mandibular 
lengths of the individuals in the small advancement group did not differ 
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significantly.  The posttreatment mandibular lengths of the individuals in the 
small advancement group did not differ significantly from untreated controls.  
However, in the large advancement group, posttreatment comparisons 
revealed that the males experienced a 2.6 mm increase in mandibular length 
and females underwent a 4.3 mm increase.  These results indicated that 
individuals with smaller mandibles, as compared to published growth 
standards, may benefit more from functional appliance therapy.  In these 
individuals, the Bionator may serve to create an optimal environment for 
increased mandibular growth. 
Lange and others (1995) conducted a study to determine the effects of 
the Bionator on the skeletal and dental tissues.  Their sample consisted of 60 
individuals with Class II division 1 malocclusions.  Of the 60, 30 were treated 
with a Bionator appliance while the other 30 did not receive any form of 
orthodontic treatment.  The four inclusion criteria consisted of the following:  
ANB of 5° or more, FMA of 20° to 29°, overjet of 6 to 10 mm, and a positive 
overbite.  Lateral cephalograms were taken before and after treatment, with 
treatment time averaging 18.7 months.  SNB increased 1.0° more in the 
Bionator group than in the control group.  Mandibular length (Ar-Gn) 
increased 6.4 mm in the treated group compared to 2.8 mm in the untreated 
group.  SNA decreased 0.5° in the Bionator group and increased 0.4° in the 
control group.  In the Bionator group, there was a reduction in ANB of 2.0°.  
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The maxillary incisors were retroclined by 3.9°, and the mandibular incisor 
angulation did not change.  These results indicate a significant skeletal and 
dentoalveolar change in the treated group; however, the patients in the sample 
were chosen based on a successful treatment outcome with the Bionator and 
not chosen at random. 
Illing et al. (1998) randomly allocated 47 adolescent patients to three 
different functional appliance groups for treatment with the Bionator, Twin-
block, or Bass appliance.  After roughly 9 months of treatment, the groups were 
compared to each other and to an untreated control group using pretreatment 
and posttreatment cephalograms.  A significant increase in mandibular length 
(3.9 mm as measured from Cd-Gn) was observed in the Bionator group as well 
as a 3.7 mm increase in the Twin-block group.  The Bionator group also 
demonstrated a significant increase in lower face height (ANS-Me).  There was 
a reduction in the proclination of the upper incisors in all of the treated groups, 
and the Bionator group exhibited the most proclination of the lower incisors 
(4.0º).  Of the three appliances, the Twin-block and the Bionator seemed to be 
the most effective in producing sagittal and vertical changes. 
Ahn, Kim and Nahm (2001) defined some cephalometric predictors for 
good treatment results when using the Bionator in the treatment of Class II 
division 1 malocclusions.  Their sample consisted of 40 patients, all of whom 
were in the mixed dentition and exhibited Class II, division 1 malocclusions.  
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They were all treated with the Bionator for an average of 20 months.  The 40 
individuals were divided into two groups based on their treatment result.  The 
criteria for a good treatment result consisted of:  (1) Class I molar, (2) overjet 
and overbite within the normal range of 1-3 mm, (3) clinically acceptable 
profile as defined by the upper and lower lips within 1 standard deviation of 
Rickett’s esthetic line, and (4) little relapse of the anterior and posterior 
relationships when assessed 2 to 5 years after Bionator therapy.  All of these 
criteria had to be met for a case to be placed in the good treatment result group, 
which consisted of 20 patients with an average age of 10.4 years.  Group 2 
consisted of 20 patients, with an average age of 10.3 years, who did not meet 
the criteria for a good treatment result.  Lateral cephalometric radiographs 
were taken before and after treatment, and they were used to assess 
orthodontic and orthopedic changes during treatment.  A horizontal growth 
pattern, close to normal anteroposterior relationship between the maxilla and 
mandible, retrusive lower incisors, and a retrusive lower lip were all identified 
as possible predictors for a good treatment result with the Bionator. 
Almeida and coauthors (2002) compared the dentoalveolar and skeletal 
cephalometric changes produced by the Fränkel and Bionator appliances in 
patients with Class II malocclusions.  The sample consisted of 66 patients 
divided into 3 groups of 22.  The first group consisted of 22 children (11 males, 
11 females with a mean age of 9 years 10 months) who were treated for an 
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average of 17 months with the Fränkel appliance.  The second group consisted 
of 22 patients (11 males, 11 females with an average age of 10 years 8 months) 
treated with the Bionator for an average of 16 months.  The control group 
consisted of 22 Class II children (mean age of 8 years 7 months) who were 
untreated but observed for 13 months.  Cephalometric radiographs were taken 
at the beginning and end of treatment.  No significant change in maxillary 
growth was observed during the observation period in either group.  However, 
a statistically significant increase in mandibular length (Cd-Gn) of 2.0 mm 
occurred in the Bionator group.  Both groups showed a slight downward 
rotation of the palatal plane, indicating no difference in craniofacial growth 
direction.  The Bionator appliance produced a labial tipping of the lower 
incisors (+2.6º) and a lingual inclination of the upper incisors (-5.5º).  In 
conclusion, the authors stated, “The major treatment effects of Bionator and FR-
II appliances were dentoalveolar, with a smaller, but significant, skeletal 
effects” (Almeida et al. 2002:464). 
Faltin et al. (2003) studied the long-term effects and optimal treatment 
timing for Class II treatment with the Bionator.  The cephalometric records of 
23 patients consecutively treated with the Bionator were evaluated and 
compared to an untreated control group.  The individuals whose treatment 
time included the pubertal growth spurt showed a significant reduction of 
overjet (-4.2 mm) and an increase in mandibular length (Cd-Gn) of 5.1 mm.  
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Their findings indicate that when treatment with the Bionator is coincident 
with the pubertal growth spurt, significant skeletal and dentoalveolar changes 
can be achieved. 
Araujo and coauthors (2004) looked at mandibular response to Bionator 
therapy in 25 patients (15 males, 10 females).  Using implants as immobile 
landmarks, each patient’s pretreatment and posttreatment radiographs were 
superimposed.  A horizontal and vertical reference line were determined by the 
implants and used to assess changes in specific mandibular landmarks (Me, 
Gn, Pg, Ar).  The functional appliance therapy changed the direction of 
condylar growth to a more posterior direction as measured from Condylion 
and Articulare.  However, this redirection of growth did not translate into an 
increased total amount of mandibular growth. 
Jena and others (2006) further investigated the dentoalveolar and 
skeletal effects of the Twin-block and Bionator appliances in the treatment of 
Class II malocclusions.  Girls (n = 55) with the same CVM status were selected 
on the following criteria:  (1) Class II division 1 malocclusion, (2) stage 3 CVM, 
(3) full-cusp Class II molar relationship, (4) FMA of at least 25°, (5) little or no 
crowding, and (6) overjet of 6 to 10 mm.  The control group consisted of 10 of 
the 55 females who were left untreated and observed until the end of the study.  
The remaining 45 patients were divided into two groups with 25 receiving 
treatment with the Twin-block appliance and 20 receiving treatment with the 
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Bionator appliance.  Lateral cephalometric radiographs were taken at the 
beginning and end of treatment,  and these were used to assess the skeletal and 
dentoalveolar changes that occurred during treatment.  Neither appliance 
significantly restricted maxillary growth.  However, the authors observed a 1.6 
and 1.0 mm increase in mandibular length (Cd-Gn) with the Twin-block and 
Bionator groups, respectively.  The maxillary molars were effectively restricted 
in both treatment groups.  The upper incisors were retroclined 0.6 mm in the 
Bionator group while the lower incisors were proclined 1.5 mm.  Both 
appliances were effective in attaining molar correction and reducing overjet, 
but the changes during treatment stemmed mostly from dentoalveolar 
compensations rather than skeletal adaptations. 
 
Characterizing the Class II Malocclusion 
In a sample of Class II individuals, Elsasser and Wylie (1943) observed 
that maxillary protrusion occurred in males while the maxilla was in a 
relatively neutral position in females.  No difference was noted in maxillary 
molar positioning compared to a Class I control group.  In addition, these 
investigators found the mandibular length to be within normal limits for males, 
while it was less than normal in females. 
Renfroe (1948) studied facial patterns in Class II malocclusions and 
observed that the maxilla was generally in a retrusive position in both sexes 
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with maxillary incisor protrusion and molar retrusion relative to a Class I 
sample.  He noted, as did Henry (1957), that while some Class II individuals 
have a deficiency in mandibular size, others have well formed mandibles of 
normal size.  However, these normal mandibles are in a retruded position due 
to the posterior position of the glenoid fossae.  Renfroe concluded that the 
mandibles of Class II individuals are retrognathic relative to other craniofacial 
structures. 
Through an investigation of Class II individuals, Riedel (1952) 
determined that the maxillary skeletal base was normally positioned in both 
sexes but with incisor protrusion.  He also noted that the mandible was 
retrusive relative to the averages of Class I individuals. 
Henry (1957) developed a classification of Class II division 1 
malocclusions.  He selected his sample according to angle’s classification 
system, and categorized four groups for this malocclusion:  (1) maxillary 
alveolar protrusion; (2) maxillary basal protrusion; (3) micromandible; and (4) 
mandibular retrusion.  From cephalometric evaluation, Henry noted an 
increased mandibular plane angle in Class II cases compared to Class I norms, 
suggesting an increase in lower facial height. 
In assessing a Class II sample, Hunter (1967) found the maxilla to be in a 
relatively neutral position, but with incisor protrusion.  The mandibular 
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skeletal position was retrognathic while the mandibular incisors were retruded.  
He also observed a slight increase in anterior facial height. 
McNamara (1981) examined a series of Class II patients to determine the 
nature and frequency of specific contributing components.  The study was a 
cross-sectional evaluation of the lateral cephalograms of 277 children ages 8 to 
10 years.  From these records, he assessed maxillary and mandibular skeletal 
and dental relationships.  The most common findings were an excessive lower 
facial height and mandibular retrusion. 
Moyers et al. (1980) in a study of 697 North American white children 
divided Class II individuals into six horizontal and five vertical groups.  Using 
a procedure of aborization, 15 subtypes of Class II malocclusions were 
established.  Analysis of these subtypes revealed persistent skeletal 
characteristics for each group during intervals of growth.  He concluded that 
20% had a maxillary protrusion while over 50% had a mandibular retrusion 
with little, if any, maxillary protrusion. 
 
Occlusal Development in Untreated Class II Malocclusions 
An indication of how to treat a malocclusion may be gained by 
observing how it changes with time.  White (1983) examined 34 patients who 
began with an end-to-end molar relationship in the early mixed dentition.  
Following these until the end of the mixed dentition, he observed that 24 
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developed a Class I molar relationship, while the other 10 developed Class II 
relationships.  The maxillary molars moved mesially an average of 2.3 mm, and 
the average mandibular increment was 1 mm in a mesial direction from the 
initial observation.  These tooth movements produced a worsening of the molar 
relationships.  White (1983) concluded that differential jaw growth was a more 
important factor in the process of molar adjustment than mesial drift of the 
molars. 
Whitney (1983) evaluated an untreated longitudinal Class II sample and 
recognized eight groups within this type of malocclusion.  The groups 
displayed an array of skeletal variations and severities of protrusiveness and 
retrusiveness of the skeletal base.  A majority of the cases were mandibular 
retrusive.  He noted a tendency for maxillary protrusion with a maxillary bony 
arch that was consistently longer than the mandibular corpus.  The differential 
between the two arches increased with age, resulting in a progressive 
worsening of the Class II relationship.  Behrents (1985) conducted a follow-up 
study of the same sample and found that, while growth continues into 
adulthood, existing maxillomandibular relationships are maintained in a fairly 
uniform manner with only small variations. 
Ngan, Byczeck, and Scheick (1997) compared skeletal growth changes 
between Class II, division 1 and Class I females between the ages of 7 and 14 
years.  Lateral cephalometric radiographs had been taken annually from age 5 
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through 17.  They observed that the maxilla was no more protrusive in the 
Class II sample when compared with the Class I sample.  In fact, there was a 
decrease in maxillary prognathism in Class II subjects during the pubertal 
growth period.  The maxillomandibular skeletal difference (ANB) was 
significantly greater in the Class II sample at age 7 and did not improve with 
age; consequently, skeletal differences maintained a greater degree of facial 
convexity in the Class II subjects.  The authors state that, “results suggest that 
the Class II skeletal growth pattern is established early and maintained 
throughout puberty unless altered by orthodontic intervention” (Ngan et al. 
1997). 
Bacetti and others (1997) observed occlusal features of the Class II 
malocclusion during the transition from the deciduous to the mixed dentition 
in untreated subjects.  During the observation period, cephalometric changes 
consisted of significantly greater maxillary growth increments and smaller 
mandibular increments in the Class II sample.  In addition, they observed a 
downward and backward rotation of the mandible over time with a 
subsequent decrease in the Gonial angle for the Class II subjects.  They 
concluded, “all occlusal Class II features were maintained or became 
exaggerated during the transition to the mixed dentition” (Bacetti et al. 1997).  
These findings are similar to those found by Fröhlich (1961) who reported that 
no improvement of Class II occlusal relationship occurs from 5 to 12 years of 
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ages and Arya and coworkers (1973) who observed that all patients presenting 
with a distal step relationship of the second deciduous molars exhibit a Class II 
relationship in the permanent dentition. 
Bishara (1988) conducted a cross-sectional and a longitudinal evaluation 
of the changes in mandibular length and maxillary-mandibular relationships in 
untreated Class II subjects from the deciduous to permanent dentition.  These 
Class II samples were compared with matched “normal,” untreated 
individuals.  Longitudinal comparisons of growth profiles indicated that the 
growth trends were similar between the untreated Class II, division 1 subjects 
and normal subjects.  There was no “self correction” with growth in the 
untreated Class II sample. 
The aforementioned literature suggests that Class II dental 
malocclusions do not “self correct” or improve with time; if anything, they 
worsen with time.  This would permit subjects with similar pretreatment Class 
II malocclusions to be compared with one another regardless of the age at the 
start of treatment. 
 
Comparison of One- and Two-Phase Treatments 
A goal of “early” orthodontic treatment is to correct existing or 
developing skeletal, dentoalveolar, and muscular imbalances to improve the 
orofacial environment before the eruption of the permanent teeth is complete 
 27 
(McNamara and Brudon 1993).  Anticipation is that early intervention may 
reduce the overall need for complex orthodontic treatment that may include 
extractions of permanent teeth or orthognathic surgery.  On the surface, this 
seems reasonable; it appears more logical to prevent an abnormality from 
occurring rather than waiting until it has developed fully.  In a recent survey of 
the 159 Diplomates of the American Board of Orthodontics, participants were 
asked what they perceived to be the benefits of early treatment (Bishara et al. 
1998).  The most common responses were:  (1) greater ability to modify growth, 
(2) improved patient self-esteem and parental satisfaction, (3) better and more 
stable results, (4) less-extensive therapy required later, and (5) reduced 
potential for tooth damage such as trauma, root resorption and decalcification.  
Responses of this survey were supported by a study by King and coworkers 
(1999) in which orthodontists perceived that subjects who had received phase 1 
treatment had less complex malocclusions and lower treatment priority than 
subjects in an untreated control. 
Proponents of two-phase orthodontic treatment often contend that 
treatment in the late mixed dentition gives the clinician only one chance at 
correction, and if cooperation is poor the results may be unsatisfactory (Dugoni 
1998).  In addition, by delaying treatment, many female patients may have 
passed the peak velocity of their skeletal growth and strategies aimed at 
growth modification may have reduced effectiveness.  According to Dugoni 
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(1998) benefits of treating Class II malocclusions in the early mixed dentition 
include the following:  (1) reduced incidence of premolar extraction, (2) 
reduced need for surgical orthodontics, (3) better patient cooperation, (4) 
reduced incidence of root resorption, and (5) reduced incidence of ectopic 
cuspid eruptions.  The Department of Orthodontics at the University of the 
Pacific is conducting a randomized retrospective study to evaluate treatment 
changes during early mixed dentition treatment (Dugoni 2006).  The study 
sample was restricted to patients who originally were evaluated in the early 
and middle mixed dentition yielding three study groups:  (1) delayed 
treatment (i.e., no treatment), (2) phase 1 treatment only, and (3) two-phase 
treatment.  All subjects were treated by the same orthodontist.  Preliminary 
analysis of the study indicates that approximately 42% of patients who 
received early treatment did not require a second phase of treatment.  Subjects 
requiring full and only phase-1 treatment had fewer visits, shorter treatment 
times, and lower fees.  In addition, 82% of subjects in the early treatment group 
did not require extraction in the permanent dentition. 
Another proposed benefit of early orthodontic intervention in Class II 
malocclusions is improved self-esteem.  O’Brien and coworkers (2003) 
conducted a multicenter, randomized, controlled trial providing early 
functional appliance treatment for children aged 8 to 10 who presented with 
Class II, division 1 malocclusions.  Comparisons were made to age and sex 
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“matched” samples that were untreated.  The second phase of the study 
examined the psychosocial impact of early orthodontic treatment.  A total of 89 
subjects were allocated to a Twin-block group and 87 to an untreated control 
group.  Data were collected at baseline and 15 months later, at which time no 
subject was still wearing the Twin-block appliance.  A series of questionnaires 
was used to gather data concerning psychosocial effects of early orthodontic 
intervention.  Results indicated that children who had received early treatment 
reported higher self-concepts and more positive childhood experiences than 
the untreated controls. 
However, not all clinicians agree, many preferring to wait until all the 
permanent teeth have erupted (excluding third molars) to start treatment.  
Opponents of two-phase treatment argue that there are few, if any, benefits 
that are unique to and dependent on earlier treatment.  Gianelly (1995) 
contends that at least 90% of all growing patients can be treated successfully in 
only one phase by starting treatment in the late mixed dentition.  Gianelly 
(1995) proposed that the other 10% of patients could benefit from immediate 
resolution of the problem such as those presenting with crossbites or Class III 
malocclusions.  Opponents of two-phase treatment contend that patients only 
have a limited capacity to cooperate, and treatments that require two phases of 
compliance and retention may be more than patients can handle (Keeling et al. 
1995; Berg 1979). 
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Opponents also contend that there is no benefit concerning self-esteem 
and early Class II treatment.  Dann and coworkers (1995) conducted research 
on children with Class II malocclusions concerning early treatment and effect 
on self-concept.  The study consisted of 209 subjects whose overjet was greater 
than 4.5 mm and who were younger than 15.  Self-concept was measured using 
the Piers-Harris children’s self concept scale, which is an 80 item “forced” 
choice self-report designed to quantitatively assess how children feel about 
themselves.  Untreated controls were used for comparison.  The results 
indicated that there was no change in mean self concept score in treated 
subjects, nor was there any association between reduction of Class II 
malocclusion features and improved self-concept.  These findings suggest that 
children with Class II malocclusions do not generally present for treatment 
with low self-concept and, on average, self-concept does not improve during 
early orthodontic treatment. 
Tulloch and coauthors (2004) conducted a randomized clinical trial of 
preadolescent (early) versus adolescent (later) treatment of children with severe 
Class II malocclusions.  Severe malocclusions were those having an overjet 
greater than 7 mm.  A total of 166 preadolescent children in the mixed dentition 
with Class II division 1 malocclusions were randomly assigned to one of three 
groups:  (1) headgear, (2) Bionator, or (3) no treatment (i.e., observation).  After 
15 months, records were taken and the groups pooled together and each child 
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was randomly assigned to one of four orthodontists for treatment with 
traditional fixed appliances.  Cephalometric radiographs were used to assess 
skeletal changes.  The peer assessment rating (PAR) was used to rate alignment 
and occlusion.  In the evaluation of Phase I treatment, statistically significant 
differences were observed between the treatment and observation groups 
although response was widely variable.  The change in jaw relationship 
(annualized reduction in ANB angle) was favorable in 76% of the headgear 
group, in 83% of the functional appliance, and in 31% of control (observation 
only) group.  Evaluation of Phase II treatment evaluated whether these changes 
represented long term changes.  Results from Phase II of the study indicate that 
the initial correction becomes overshadowed with time.  Differences among 
groups with respect to skeletal relationship and PAR score were not 
statistically significant at the end of Phase II treatment.  In addition, two-phase 
treatment appeared to be inefficient in that it did not reduce the average time a 
child spent in fixed appliances nor did it reduce the complexity of later 
treatment (need for extraction or orthognathic surgery).  “During phase 2 of the 
trial, the advantage created during phase 1 of treatment in the two early 
treatment groups was lost, and, by the end of fixed appliance treatment, there 
was no significant difference between any of the three groups” (Tulloch et al. 
2004:660). 
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O’Brien and coauthors (2003) evaluated the effectiveness of early 
orthodontic treatment with a Twin-block functional appliance in a multicenter, 
randomized clinical trial.  In comparison to the study conducted by Tulloch 
and coauthors (2004), this study used 14 hospital-based orthodontic specialists 
in the United Kingdom.  Importantly, treatment was provided by many 
operators outside of a controlled university setting.  In summary, the authors 
wanted to see how effective early Class II treatment is in the “real world” of 
orthodontic practice outside dental schools.  Children (n = 174), aged 8 to 10 
years with Class II, division 1 malocclusions were randomly allocated to 
receive treatment with the Twin-block appliance or to an untreated control 
group.  Data were collected at the start of the study and 15 months later.  The 
results showed that treatment with the Twin-block appliance reduced overjets, 
corrected molar relationships, and reduced the severity of the malocclusions.  
The majority of the correction was attributed to dentoalveolar changes and 
small amounts of favorable skeletal change.  The study continued until the 
children had completed phase 2 treatment.  Operators treated the children 
according to their normal treatment protocols.  An aim of the study was to 
learn whether early treatment resulted in a reduced need for phase 2 treatment, 
and if differences in skeletal pattern or final dental occlusion were evident.  At 
the end of phase 2 treatment, there was no difference between the patients who 
had early treatment and those who did not for any variable evaluated, and 
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most treated subjects required a second phase of treatment.  In conclusion, 
these findings agree with the those of Tulloch and coauthors (2004) in that it 
appears that early orthodontic treatment for Class II malocclusions does not 
confer any advantage over a later single-phase treatment. 
Breman and Pancherz (2002) studied the efficiency of early and late 
Class II division 1 treatment.  Efficiency was defined as a better result in a 
shorter time.  Pretreatment and posttreatment dental casts of 204 patients in the 
early mixed (n = 54), late mixed (n = 104), and permanent (n = 40) dentition 
were evaluated according to the peer assessment rating (PAR).  Results showed 
that treatment time and PAR scores decreased with increasing dental 
development, indicating that early Class II division 1 treatment is less efficient 
and less successful than a later one-phase treatment. 
Livieratos and Johnston (1995) conducted a study comparing one-stage 
and two-stage nonextraction alternatives in Class II samples.  For all subjects, 
the clinician’s initial intention was non-extraction therapy, either in a one-stage 
full appliance or two-stage Bionater and full appliance treatment.  The study 
sample consisted of 47 one-stage patients and 49 two-stage patients, all treated 
by a single orthodontist.  Comparisons between the two groups were 
conducted by examining pretreatment and posttreatment lateral cephalograms.  
Both groups exhibited similar patterns of skeletal change that could not be 
distinguished from each other.  Skeletal changes, in both groups, were largely 
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responsible for molar and overjet corrections.  The magnitude of differential 
jaw growth was greater in the two-phase group, presumably because treatment 
started earlier and finished later. 
Dolce et al. (2005) conducted a similar comparison and observed an early 
mandibular response in patients treated with a Bionator.  The data revealed 
that the sagittal jaw relationship improved significantly in both Phase 1 
treatment groups compared with the observation group.  However, this initial 
mandibular response was not evident after both groups had received full 
appliance therapy.  This study differed from previous studies in that it used 
centrographic analysis.  The centrographic analysis is a visual analysis with no 
angles to measure or normative values to compare.  Landmark position relative 
to an established reference plane allows the tracking of landmarks in horizontal 
and vertical planes. 
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CHAPTER III 
MATERIALS AND METHODS 
 
Sample Selection 
This present study is a retrospective analysis of cephalograms from 
patients with Class II, division 1 malocclusions at the start of treatment.  There 
were 50 consecutively treated patients who received phase 1 (early) treatment 
with a Bionator appliance and later treatment with full fixed appliances.  
Cephalometric radiographs were available at T0 (start of treatment), T1 (end of 
phase 1 treatment), and T2 (end of treatment) for these subjects.  Records were 
obtained from the office of Dr. Joe L. Wasson, Memphis, Tennessee, who had 
treated all of these cases.  The control group consisted of a sample of subjects 
with the same Class II, division 1 malocclusions who were treated at the 
University of Tennessee, Department of Orthodontics, with fixed appliances 
only (Standard Edgewise). 
 
Matching Criteria 
The author devoted considerable time collecting data to provide a case-
control matched sample of cases treated orthodontically.  As noted above, the 
principal focus of the study was to evaluate the treatment outcomes of two 
samples, (1) a series first treated in the mixed dentition with the Bionator then 
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transitioned into fixed Edgewise treatment and (2) a series treated in just one 
phase using conventional Edgewise mechanisms (Sandusky and Gramling 
1988) in the early permanent dentition. 
The commonly encountered design is to use a group comparison design, 
where the average characteristics of the two groups are argued to be 
comparable.  This is expedient, but statistically much less efficient than 
comparing matched samples.  In contrast, we first evaluated the two-phase 
sample and matched an Edgewise case to each based on what we deemed key 
characteristics of the skeletal malocclusion. 
Necessarily, the chronological ages are different in the two groups at the 
start of treatment, and the issue here is that cephalometric measures of size and 
shape change as a child grows and develops.  We matched the 50 two-phase 
cases to 50 conventional Edgewise cases using five cephalometric criteria 
reflective of the bony facial profile, namely (1) the SNA angle, (2) the SNB 
angle, (3) the ANB angle, (4) the NAP angle, and (5) the FMA angle using the 
following protocol:  The average age at the start of Bionator treatment was 9 
years, while the average age at the start of Edgewise treatment in this sample 
was 13 years.  We used a simple, pattern extension method (Johnston 1975) to 
extrapolate from the 13-year-old status back to 9 years of age when Bionator 
treatment was initiated, a difference, obviously, of 4 years.  As shown from the 
data on normal untreated children published by Riolo et al. (1974), there are 
 37 
only minor age changes in the angular variables of interest here (Table 1).  That 
is, while there is appreciable linear growth during this interval, the shape 
(angular) changes in these variables are small, with the largest changes 
occurring in NAP as mandibular growth slightly exceeds maxillary forward 
growth, so the typical profile becomes less retrognathic with age. 
For each Bionator case (at about 9 years of age), the pool of Edgewise-
treated cases was reviewed to provide a close match for the five variables.  
Operationally, we felt there was adequate precision if all the five variables 
“matched” within 1 or 2 degrees of the 9-year-old Bionator case accounting for 
the characteristic sex-specific age changes listed in Table 1.  Pointedly, we made 
no special effort to match for dental characteristics of the malocclusion, though 
all cases began treatment as Class II, division 1 malocclusions. 
Table 2 lists the sample means for the two series along with the results of 
pairing design t-tests (Woolf 1968).  This table is expanded to 10 variables, 
which is more than the 5 actually used for the matching process, but the results 
are confirmatory that our efforts to match the Edgewise cases with 
cephalometrically quite-similar two-phase cases was successful.  All 5 of the 
cephalometric variables thought to be most critical (SNA, SNB, ANB, NAP, and 
FMA) fulfilled expectations of being comparable after accounting for the 
chronological age difference.  Indeed, of the 10 variables compared in Table 2 
the Edgewise sample was more aberrant, which is in keeping with these 
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Table 1.  Average changes of key cephalometric variables from 9 to 13 years of 
age.1 
 
  Boys   Girls  
 Variable 9 yr 13 yr Change 9 yr 13 yr Change 
 SNA 80.6° 81.2° +0.6° 80.5° 81.0° +0.5° 
 SNB 76.4° 77.5° +1.1° 76.5° 77.5° -1.0° 
 ANB 4.2° 3.7° -0.5° 4.0° 3.5° -0.5° 
 NAP 8.0° 6.1° -1.9° 7.6° 5.4° -2.2° 
 FMA 29.5° 20.0° -0.5° 28.4° 26.0° -2.4° 
1Data from Riolo et al. (1974). 
 
Riolo ML, Moyers RE, McNamara JA Jr, Hunter WS.  An atlas of craniofacial 
growth:  cephalometric standards from the University School Growth Study, 
the University of Michigan.  Monograph 2, Craniofacial Growth Series.  Ann 
Arbor:  Center for Human Growth and Development, University of Michigan; 
1974. 
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Table 2.  Evaluation of the two samples at the start of treatment.1 
 
 Bionator Edgewise Mean 
Variable Mean Mean Difference n t-test P-Value 
 NAP 9.84 9.70 -0.14 50 -0.25 0.8012 
 SNA 81.86 82.08 0.21 50 0.33 0.7454 
 SNB 76.23 76.61 0.38 50 0.58 0.5652 
 ANB 5.64 5.47 -0.17 50 -1.14 0.2601 
 AOBO 3.48 4.85 1.36 50 3.35 0.0016 
 FMA 26.02 26.71 0.69 50 1.46 0.1507 
 IMPA 94.46 94.99 0.53 50 0.38 0.7023 
 FMIA 59.52 58.29 -1.24 50 -0.96 0.3432 
 Overbite 3.67 2.99 -0.68 50 -1.53 0.1323 
 Overjet 6.43 6.94 0.51 50 1.04 0.3041 
1Sample means at the start of treatment; t-tests are pairing design t-tests. 
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children being 4 years older, with more exacerbated malocclusions. 
We pointedly did not worry about matching cases on dental variables because 
the avowed merits of two-phase treatment are to improve the basal bony 
relationships and facial profile (McNamara and Brudon 1993).  Expectation was 
that the fixed phase of treatment could comparably correct dental 
malocclusions, whether in one phase or during the fixed phase of compound 
treatment. 
 
Sample Description 
Dr. Joe L. Wasson, Memphis, Tennessee employs a three-tier treatment 
strategy for Class II malocclusion treatment.  The patients that fall under the 
first tier tend to be in the early mixed dentition (7 to 10 years of age), with high 
mandibular plane angles, openbite tendencies, and deleterious oral habits (e.g., 
tongue thrusts).  In addition, these patients tend to have large overjets and 
constricted or underdeveloped dental arches.  Treatment of these patients 
typically occurs in a two-phase regimen.  The first phase consists of Fränkel II 
wear for approximately 22 hours a day for 1 year followed by a retention 
phase, wearing the appliance for 8 to 12 hours a day.  A second phase of fixed 
appliances is started once all of the permanent teeth are present. 
The second tier of the treatment triage is geared to patients who have 
Class II division 1 malocclusions.  These patients have low mandibular plane 
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angles and deepbite tendencies.  These patients are somewhat older than the 
Fränkel patients but are still in the mixed dentition (8 to 11 years of age).  
Again, a two-phase regimen is employed for these patients.  The first phase 
involves full-time Bionator wear for at least 9 to 12 months with 6 to 8 week 
appointment intervals to assess progress.  After initial correction, the appliance 
is worn at night for retention while waiting on the rest of the permanent 
dentition.  The second phase involves fixed appliances in order to detail and 
finish the case. 
The third treatment strategy is aimed at Class II patients in the early 
permanent dentition (11 to 14 years of age).  This group of patients often is 
treated with fixed functional appliances such as the Herbst appliance and 
MARA (i.e., mandibular advancement repositioning appliance). 
 
Class II Characteristics of the Sample 
There are several “sorts” of Class II malocclusions depending on 
whether the problem is dental or skeletal and depending on which jaw is more 
deviant (i.e., maxillary excess, mandibular retrognathia, or some combination 
of the two).  The purpose here is to test whether the one- and two-phase 
samples compared here differed as to the offending skeletal problem.  Three 
key angular variables were compared at the start of treatment, namely SNA, 
SNB, and ANB. 
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Starting ages for the two- and one- phase treatments are years apart (9.6 
and 13.1 years, respectively), but the normative angular relationships change 
very little across this age span (e.g., Riolo et al. 1974). 
These three cephalometric measures of parasagittal jaw relationships 
(SNA, SNB, ANB) do not differ statistically between groups (Table 3).  Means 
for SNA are 82° in both groups (F = 0.1; P = 0.7613).  There is just one case in 
each sample with an SNA exceeding 90° (i.e., 91°).  None of the cases in the 
two-phase group has an SNA below 75°, but 3 of the one-phase cases are in the 
70° to 75° range. 
Data from Riolo et al. (1974) shows that normative SNA is very close to 
81° (sd = 3.5°) throughout this age span, so just four of the 100 cases are beyond 
2 sd (about 88°); 3 of these are 2-phase cases and 1 case in the one-phase 
sample. 
Means for SNB average 76° in the two-phase group and 77° in the one-
phase group, which is indistinguishable statistically (F = 0.3; P = 0.5626).  All 
cases have SNB values between 70° and 85°.  Normative standards for SNB in 
this age interval are close to 78° (sd = 3.5°), indicating that 6 cases from among 
the 100 here have SNBs between -2.0 and -2.5 standard deviations of the mean 
(and none below -2.5 sds). 
The range of ANB angles are all within 1° and 9°, with no statistical 
difference between the two samples (F = 0.3; P = 0.5883).  Mean ANB is the  
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Table 3. Tests for group differences in the parsagittal measures of jaw 
relationships. 
 
  Two Phase   One Phase   ANOVA  
 Variable n mean sem n mean sem F Ratio P value 
 SNA 50 81.86 0.49 50 82.08 0.49 0.09 0.7613 
 SNB 50 76.23 0.47 50 76.61 0.47 0.34 0.5626 
 ANB 50 5.64 0.22 50 5.47 0.22 0.29 0.5930 
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same, 5.5°, in both groups, which is not far above the normative standard of 
about 4° (sd about 2.5°) in this age interval.  None of the cases in either groups 
here has an ANB beyond 2 standard deviations, which is about 9°. 
 
Bionator Appliance Design 
The following description presents an outline of features and functions 
of the Bionator appliance.  The reader is referred to the texts by Graber and 
Neumann (1984) and McNamara and Brudon (1993) for actual construction of 
the appliance.  Varying configurations of the Bionator are utilized to open, 
close, or maintain the bite in conjunction with posturing the mandible forward 
into a more desirable position.  For the purposes of this study, the Bionator that 
is used to open the bite was employed during the initial phase of treatment, 
and this is shown in Figures 1 through 3.  The following items are a list of the 
components that make up the appliance: 
• Upper Labial Wire:  This wire (0.040”) is bent in a Hawley configuration 
with adjustment loops the same width as the canines and extending 
upward 7 to 8 mm above the gingival margin.  The labial bow lies along the 
anterior teeth with roughly 0.5 mm of clearance to avoid lingual tipping of 
the upper incisors. 
• Upper Lingual Wire:  This wire (0.036”) provides support for the appliance 
by using the lingual surfaces of the upper anterior teeth for anchorage.  It is  
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 Figure 1.  Occlusal view of Bionator appliance used in the study.  The palatal 
bar acts to stabilize the appliance and also gives the tongue a place to rest.  The 
Adams clasps fit to the maxillary first molars for retention.  Behind the labial 
bow is a wire that can be cut and activated if needed to keep the upper incisors 
from tipping lingually. 
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 Figure 2.  Lateral view of Bionator appliance used in the study.  Here the facets 
can be seen that permit eruption of the posterior teeth to help open the bite.  
The incisors are fully covered with acrylic to prevent unwanted flaring. 
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 Figure 3.  Frontal view of Bionator appliance used in the study.  This view 
shows the appliance in full with the tongue space and palatal bar, labial bow, 
Adams clasps for retention, and the full coverage of acrylic for the lower 
incisors. 
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constructed in an ideal arch form and lies at the level of the cingula.  It can 
also be cut between the central incisors and activated if the incisors have 
been tipped lingually. 
• Palatal Wire:  This wire (0.045”) or “Coffin spring” is constructed to lie 2 to 
3 mm off the palatal tissue for comfort and can be activated for lateral arch 
development if needed. 
• Eruption Facets:  These can me made from the interocclusal acrylic to 
facilitate the eruption of both the upper and lower posterior teeth if desired.  
These pathways or channels are oriented so that the posterior teeth erupt  
either vertically or laterally. 
• Occlusal Table:  One method employed for Class II correction is the 
differential eruption of teeth.  An occlusal table can be fabricated so that the 
upper posterior teeth are in contact with the acrylic, while the lower 
posterior teeth are allowed to erupt.   
• Interocclusal Acrylic:  If no eruption of the posterior teeth is desired, the 
interocclusal acrylic is designed so that the posterior teeth touch the acrylic 
evenly. 
• Lower Incisor Coverage:  The occlusal coverage prevents vertical eruption 
or labial tipping of the lower incisors, and it also stabilizes the appliance in 
the mouth. 
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The appliance design is less bulky than the original activator, therefore 
speech is not affected, and it can be worn continuously (McNamara and 
Brudon 1993). 
 
Goals of Bionator Therapy 
The intended goal of functional appliance therapy is to create an 
environment whereby an individual’s full growth potential can be realized and 
utilized to help correct the malocclusion.  Eirew (1981), summarizing Balters’ 
original treatment objectives, lists the goals of Bionator therapy as follows:  (1) 
the elimination of a lip trap and abnormal relationship between the lips and 
incisor teeth; (2) the elimination of any mucosal damage due to an impinging 
overbite; (3) the correction of mandibular retrusion or retrognathia and faulty 
tongue positioning; and (4) the correction of the occlusal plane (Graber and 
Neumann 1984).  In the present study, the Bionator was used to:  (1) allow for 
continued eruption of the posterior teeth to open the bite and increase lower 
facial height; (2) propulse the mandible forward in hopes of maximizing the 
patient’s growth potential; (3) achieve a Class I molar relationship; (4) gain 
some early skeletal correction (achieve a more orthognathic bony profile); (5) 
reduce the existing overjet; and (6) reduce the complexity and treatment time of 
the subsequent fixed appliance phase of treatment. 
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Cephalometric Analysis 
Lateral cephalometric radiographs from three time points were used for 
the group being studied:  (1) the pretreatment examination; (2) at completion of 
phase 1 treatment; and (3) at completion of full appliance treatment.  
Descriptive statistics for each cephalometric examination are listed in 
Appendix A.  Since the control group was treated with fixed appliances in a 
single phase, only pretreatment and posttreatment radiographs were available 
for that group.  A total of 28 angular and linear variables were used in this 
analysis.  The following alphabetical listing provides definitions of the 
cephalometric landmarks used in the study: 
A Point A (Subspinale):  the most posterior point on the exterior ventral 
curve of the maxilla between the anterior nasal spine and Supradentale. 
ANS Anterior Nasal Spine:  the spinous process of the maxilla forming the 
most anterior projection of the floor of the nasal cavity. 
B Supramentale:  the most posterior point on the bony curvature of the 
mandible between Infradentale and Pogonion. 
Ba Basion:  the most inferior-posterior point in the midsagittal plane on the 
anterior margin of the foramen magnum at the base of the clivus. 
Cd Condylion:  the most superior and posterior point on the curvature of 
the capitulum of the condyle. 
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DOP Downs’ Occlusal Plane:  the line that vertically bisects incisal overbite 
and the most anterior occlusal contact of the maxillary and mandibular 
first molars (Downs 1948). 
Gn Gnathion (anatomic):  the most anterior-inferior point of the mandibular 
symphysis. 
Go Gonion (anatomic):  the most posterior-inferior point on the Gonial 
angle of the mandible. 
Ii Incision inferius:  the incisal tip of the most anterior mandibular central 
incisor. 
Is Incision superius:  the incisal tip of the most anterior maxillary central 
incisor. 
LIA Apex of mandibular central incisor:  the apical end of the same 
mandibular central incisor used to locate Ii. 
L6C L6 cusp:  the mesial cusp tip of the mandibular first molar. 
Me Menton:  the most inferior point on the symphysis of the mandible. 
Na Nasion:  the anterior point of the intersection between the nasal and 
frontal bones. 
Or Orbitale:  the most inferior point on the lower margin of the bony orbit. 
Pg Pogonion:  the most anterior point on the anterior contour of the bony 
chin below B point and above Gnathion. 
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PNS Posterior Nasal Spine:  the most posterior point at the midsagittal plane 
on the bony hard palate. 
Po Porion:  the midpoint on the superior aspect of the rim of the external 
auditory meatus. 
Pt Pterygomaxillary fissure:  the most superior-posterior point on the 
radiographic outlines of end the pterygomaxillary fissure. 
Se Sella turcica:  the center of the hypophyseal fossa, determined by 
inspection. 
U1A Apex of the maxillary central incisor:  the apical of the most anterior 
maxillary central incisor of the same tooth used to locate Is. 
U6C U6 cusp:  the mesial cusp tip of the maxillary first molar. 
 
Data Entry 
The cephalometric radiographs from all subjects were scanned using a 
UMAX Powerlook III flatbed scanner at 300 dpi and 256 gray scale, and the 
scans were saved as TIFF files.  The radiographs in TIFF format were imported 
into Dolphin Imaging® 10.0 and traced using the program’s digital 
cephalometric tracing package.  Prints of the cephalometric tracings of all the 
subjects used in the present study can be found in Appendix B.  A custom 
analysis was created with the “custom analysis builder” function of Dolphin 
Imaging for measurement of the 28 skelotodental angular and linear variables 
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used in the present study.  The measurements were exported from Dolphin 
Imaging into Microsoft Excel® 2003 and then into JMP® 5.0.2 (SAS Institute Inc. 
Cary, NC) for statistical analysis. 
 
Statistical Analysis 
Data were collated into an Excel spreadsheet (Microsoft®) then 
transferred to the JMP statistical package (SAS Institute Inc., Cary, NC).  
Exploratory data analysis (Tukey 1977) was performed, searching for outliers; 
those due to technical errors were corrected.  Conventional descriptive 
statistics (e.g., Sokal and Rohlf 1995) were calculated; these (and their 
abbreviations) are sample size (n, taken as counts of individuals, not sides), the 
arithmetic mean ( x ), the standard deviation (sd), and the standard error of the 
mean (sem, calculated as sd/√n).  The conventional alpha level of 0.05 was 
used throughout, and all of the tests were two-tail.  No correction was made for 
multiple comparisons.  Salient results of the analysis were graphed using Delta 
Graph® 4.0.5 for the PC. 
The data were used to compare treatments with regard to (1) whether 
changes occurred during the first phase treated with a functional appliance, (2) 
whether changes occurred during the second phase treated with a fixed 
appliance, and (3) whether the amounts of change differed between the two 
phases for the experimental group.  The differences were calculated at the start 
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of treatment and the progress record, then between the progress record and the 
end of treatment.  One sample t-tests (two tail) were used to evaluate changes 
in variables across time as a function of the sample variability.  Repeated 
measures analysis of variance (Winer et al. 1991) was used to determine if the 
change from phase 1 to progress differed significantly from the change 
observed in phase 2.  The skeletodental landmarks and angular measurements 
used in this study are illustrated in Figures 4 through 22. 
Statistical descriptions for the one-phase treatment group were 
calculated by obtaining the descriptive statistics for the sample at the two 
examinations, and then separately using pairing-design t-tests to assess 
whether the treatment change differed significantly from the null hypothesis of 
no change (two tail).  To assess how comparable the skeletodental variables 
were at the end of treatment, we calculated the difference in the arithmetic 
means of the one- and two-phase groups.  In addition, a paired t-test was 
calculated to determine if the two groups differed statistically. 
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Figure 4. Cephalometric diagram showing locations of the skeletodental 
landmarks to be used in this study. 
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Figure 5.  Schematic tracing of a lateral cephalogram showing construction of 
the SNA angle. 
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Figure 6.  Schematic tracing of a lateral cephalogram showing construction of 
the SNB angle. 
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Figure 7.  Schematic tracing of a lateral cephalogram showing construction of 
the ANB angle. 
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Figure 8.  Schematic tracing of a lateral cephalogram showing construction of 
the angle of convexity (NAP).  This is the superior-anterior angle at the 
intersection of the Nasion-A and the A-Pogonion lines. 
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Figure 9.  Schematic of the method of measuring the AOBO discrepancy.  Point 
A and Point B are projected orthogonally onto the functional occlusal plane.  
AOBO is the millimetric distance between the projected line segment along the 
occlusal plane. 
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Figure 10.  Schematic tracing of a lateral cephalogram showing construction of  
FMA.  This is the angle formed by the intersection of Frankfort Horizontal and 
the line through anatomic Gonion and Menton. 
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Figure 11.  Schematic tracing of a lateral cephalogram showing construction of 
the angle formed by the intersection of Frankfort Horizontal and the Se-Na 
line. 
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 Figure 12.  Schematic tracing of a lateral cephalogram showing construction of 
Sella-A Point linear distance measurement.  The distance between the two 
points is measured in millimeters. 
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Figure 13.  Schematic tracing of a lateral cephalogram showing construction of 
Downs’ facial angle.  This is the angle formed by the posterior-inferior 
intersection of Frankfort Horizontal and Nasion-Pogonion lines. 
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Figure 14.  Schematic tracing of a lateral cephalogram showing construction of 
the A Point to Nasion-Perpendicular (labeled D) and B Point to Nasion-
Perpendicular (labeled D’) measurements.  Both distances are measured 
parallel with Frankfort horizontal in millimeters. 
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Figure 15.  Schematic tracing of a lateral cephalogram showing construction of 
Sella-B Point linear distance measurement.  The distance between the two 
points is measured in millimeters. 
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Figure 16.  Schematic tracing of a lateral cephalogram showing construction of 
the angle of the mandibular incisor and the mandibular plane (IMPA). 
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Figure 17.  Schematic tracing of a lateral cephalogram showing construction of 
FMIA measurement.  This is formed by the intersection of Frankfort Horizontal 
and the long axis of the mandibular incisor (L1 apex and L1 incisal edge). 
 69 
θL1a
L1i
U1a
U1i
 
Figure 18.  Schematic tracing of a lateral cephalogram showing construction of 
the angle between the upper incisor with the lower incisor (i.e., interincisal 
angle). 
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Figure 19.  Schematic tracing of overbite and overjet measurements. 
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Figure 20.  Schematic tracing of a lateral cephalogram showing construction of 
the Y-axis angle.  This is the anterior-inferior angle at the intersection of 
Frankfort Horizontal and the Sella-Gnathion line. 
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Figure 21.  Schematic tracing of a lateral cephalogram showing construction of 
the Downs’ occlusal plane angle.  This is the angle formed by the intersection of 
Frankfort Horizontal and Downs’ occlusal plane. 
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Figure 22.  Schematic tracing of a lateral cephalogram showing construction of 
the Condylion to Gnathion. 
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CHAPTER IV 
RESULTS 
 
Extractions 
The manifest reason to extract teeth as part of orthodontic treatment is to 
alleviate tooth-size arch-size discrepancies (TSASD), but, in practice, many 
additional considerations come into play.  In this study, extractions as part of 
orthodontic therapy were far more common in the one-phase group.  Overall, 
just premolars were extracted, and the frequency was 12% (6/50 cases) in the 
two-phase series compared to 84% (42/50) in the one-phase series.  This 
difference is highly significant statistically by chi-square analysis. 
 
Time in Treatment 
A common criticism of two-phase treatment (by those averse to it) is that 
is takes longer.  A longer interval is evident in the present study (Table 4).  
Children in the Bionator group began treatment at an average of 10.0 years, 
with this phase lasting an average of 1.4 years.  This was followed by fixed 
treatment that began at an average age of 12.0 years, lasting 2.2 years.  There 
was, on average, a gap of 0.5 years between the Bionator and the fixed phase.  
Overall treatment lasted from about 10 to 14 years of age, a duration of 4.2 
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Table 4. Descriptive statistics of the examination dates, by group. 
 
 Examination X¯ sd sem L1 L2 n 
Edgewise Treatment 
Starting Age 13.15 1.39 0.20 12.76 13.55 50 
Age at End 15.98 1.84 0.26 15.45 16.50 50 
Treatment Time 2.82 1.31 0.18 2.45 3.19 50 
Bionator + Edgewise Treatment 
Starting Age 10.05 1.40 0.20 9.66 10.45 50 
End Phase 1 11.45 1.44 0.20 11.04 11.86 50 
Time in Phase 1 1.40 1.15 0.16 1.07 1.72 50 
Start Phase 2 12.05 1.31 0.19 11.68 12.43 49 
End Phase 2 14.31 1.53 0.22 13.87 14.74 50 
Time in Phase 2 2.24 0.88 0.13 1.99 2.49 49 
Treatment Time 4.25 1.33 0.19 3.88 4.63 50 
Treatment Time* 3.65 1.41 0.20 3.24 4.05 49 
 
*Time in treatment omitting the interval between phases. 
 76 
years.  If the interval between the two phases is omitted, overall duration 
reduces to 3.6 years. 
In contrast, single-phase treatment commenced at an average of 13.1 
years, with an average duration of 2.8 years.  Consequently, overall treatment 
time was longer in the two-phase sample (by an average of 1.4 years, or 17 
months).  The fixed phase was, as often-noted in prior studies, somewhat 
shorter in the two-phase groups (2.2 versus 2.8 years, a difference of 6 months).  
Ages at termination of treatment also were different:  Patients treated in two 
phases were completed at 14 years of age compared to 16 years of age in the 
single-phase series.  This means that the average Bionator patient would be 
debonded when a freshman in high school versus a junior. 
 
Changes between Phases 
Goals of the Bionator phase of treatment are fundamentally different 
from those of later fixed treatment.  Cephalometric changes during these two 
phases are contrasted in this section.  Because a cephalogram was taken at the 
end of the Bionator phase, we could quantitatively compare the changes in 
each variable between these two, successive phases.  A mixed-model ANOVA 
design was used, since identically the same patients were followed across the 
two phases, and sex of the subjects was included in the model since boys’ and 
girls’ craniofacial growth vectors are apparently different (van der Linden 1986; 
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Harris 2001).  The mean changes during the first and second phases of 
treatment are listed in Table 5.  Notice that there are two sets of figures here; 
the first two columns of numbers are the means during the two phases having 
pooled males and females, while the next four columns provide data for boys 
and girls separately.  Table 6 lists the results of the mixed model ANOVA.  
There are three tests for each variable (each row):  The first F-ratio tests 
whether boys and girls responded differently during treatment; the second F-
ratio tests whether the amount of change differed between Bionator and 
Edgewise phases; and the third F-ratio tests whether there was a significant 
sex-by-phase interaction effect.  These comparisons only pertain to when the 
changes occurred in the two-phase group; no comparison is made here to the 
conventional Edgewise sample. 
The duration of the two phases of treatment were fairly equal, namely 
an average of 2.1 years in Bionator treatment and an average of 2.3 years in 
fixed appliances thereafter. 
 
Integument 
Of the two variables assessed here (Z angle and E plane), neither 
differed in magnitude of change between the two phases (Figures 23, 24).  The 
E plane changed less in boys than girls (Figure 24), but the clinical significance 
of this minor sex difference (if any) is not apparent. 
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Figure 23. Mean changes in the Z angle during phase one (1) and phase two (2) 
of compound orthodontic treatment, by sex. 
 83 
 
 
Figure 24. Mean changes in the E Plane during phase one (1) and phase two (2) 
of compound orthodontic treatment, by sex. 
 84 
Skeleton 
Changes did not differ between the two groups for the Y-axis (Figure 25) 
or for the NAP angle (Figure 26).  However, the three variables that depend on 
Nasion (i.e., SNA, SNB, and ANB) show significantly more change during the 
fixed phase than during the Bionator phase (Figures 27-29).  None of these 
three changes was sexually dimorphic.  SNA changed slightly ( x  = 0.2º) during 
Bionator phase, but then decreased significantly ( x  = -1.7º) during the Bionator 
treatment but almost not at all during the fixed phase ( x  = -0.1º).  The net effect 
is that ANB, a measure of maxillomandibular discrepancy, improved 
(decreased) significantly more in phase 1 ( x  = -1.9 º) than phase 2 ( x  = -1.1 º). 
This overall decrease in ANB ( x  = 3.1º) is readily assuaged with the 
statement above that the mean change in NAP was not significant (Table 5).  
The ANOVA tests in Table 6 evaluate whether there is a difference in the 
amounts of change between the two phases, not whether the changes are 
statistically different from zero (i.e., no systematic change).  Consequently, the 
test for NAP in Table C2 merely means that the change during the Bionator 
change ( x  = -3.7º) was not different statistically from that during the later fixed 
phase ( x  = 3.3º). 
SNA and SNB both changed significantly more during one phase than 
the other, but in complementary fashions (Figures 26, 27).  SNA decreased  
 85 
 
 
Figure 25. Mean changes in the Y-axis angle during phase one (1) and phase 
two (2) of compound orthodontic treatment, by sex. 
 86 
 
 
Figure 26. Mean changes in the NAP angle during phase one (1) and phase two 
(2) of compound orthodontic treatment, by sex. 
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Figure 27. Mean changes in the SNA angle during phase one (1) and phase two 
(2) of compound orthodontic treatment, by sex. 
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Figure 28. Mean changes in the SNB angle during phase one (1) and phase two 
(2) of compound orthodontic treatment, by sex. 
 89 
 Figure 29. Mean changes in the ANB angle during phase one (1) and phase two 
(2) of compound orthodontic treatment, by sex. 
 90 
significantly more during the fixed phase, while SNB increased significantly 
more during the Bionator phase. 
The composite change in the two jaws (i.e., ANB angle) was a decrease 
that averaged -3.1º.  Figure 29 shows that most of the change in ANB occurred 
during the Bionator phase of treatment, probably because propelling the 
mandible forward is a specific aim of the Bionator device.  Indeed, the change 
was significantly greater during the Bionator phase (P < 0.003). 
AOBO (the Wits discrepancy) is another measure of maxillomandibular 
harmony.  Considerably more of the overall improvement of 2.9 mm occurred 
during the Bionator phase (Figure 30).  The AOBO discrepancy averaged 3.5 
mm at the start of treatment in the two-phase sample.  The average reduction 
of 2.9 mm, mostly achieved with Bionator treatment, left the group with a 
mean AOBO of 0.6 mm, which is within desired limits (Jacobson 1976, 1988). 
In this same vein (i.e., SNA, SNB, ANB, and AOBO changes), the facial 
angle changed (increased) significantly more during the Bionator phase of 
treatment, a difference of 1.9º versus 0.5º during the fixed phase (Figure 31).  
These measures of inter-arch relationships show that there was appreciable 
improvement with the compound treatment, and most of the skeletal 
correction was achieved during the earlier, Bionator phase. 
The FMA changed little overall, and the difference in change between 
the two phases was not significant (Figure 32). This consistency argues in 
 91 
 
Figure 30. Mean changes in the AOBO Discrepancy during phase one (1) and 
phase two (2) of compound orthodontic treatment, by sex. 
 92 
 
Figure 31. Mean changes in the facial angle during phase one (1) and phase 
two (2) of compound orthodontic treatment, by sex. 
 93 
 
 
Figure 32. Mean changes in the FMA during phase one (1) and phase two (2) of 
compound orthodontic treatment, by sex. 
 94 
 favor that proper orthodontic mechanics were maintained so there was no loss 
of vertical control. 
The three measures of linear change in facial depth, namely (1) 
mandibular length (Figure 33), (2) Sella-A Point length (Figure 34), and (3) 
Sella-B Point length (Figure 35), all exhibit significantly more growth during 
the Bionator phase of treatment than during the later fixed phase of treatment.  
Of note, these greater rates of growth during the Bionator phase occurred 
during an average of 9.5 and 11.5 years of age, which, especially in boys, 
precedes the adolescent growth spurt (Tanner 1962).  Growth of these three 
dimensions also is obvious during the fixed phase, but at significantly slower 
rates (Table 5). 
Two variables were specifically included to evaluate changes in the bony 
facial profile.  These are the distances to A Point and to B Point, each measured 
relative to Nasion-Perpendicular (Figures 36, 37).  Both of these dimensions 
changed to significantly different extents during the two phases of treatment, 
but in complementary fashions.  A Point changed almost not at all during 
Bionator treatment, but then dropped back ( x  = 1.1 mm) farther from Nasion-
Perpendicular during the fixed phase.  In contrast, B Point grew forward an 
average of 2.7 mm during the first phase, but then likewise dropped back a bit 
( x  = 0.2 mm) during fixed treatment.  The discrepancy between points A and B 
decreased to an average of 6.8 mm at the end of the Bionator phase.  This  
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Figure 33. Mean changes in the Mandibular Length during phase one (1) and 
phase two (2) of compound orthodontic treatment, by sex. 
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Figure 34. Mean changes in the Sella-A Point Length during phase one (1) and 
phase two (2) of compound orthodontic treatment, by sex. 
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Figure 35. Mean changes in the Sella-B Point Length during phase one (1) and 
phase two (2) of compound orthodontic treatment, by sex. 
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Figure 36. Mean changes in A Point to Na-Perp Distance during phase one (1) 
and phase two (2) of compound orthodontic treatment, by sex. 
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Figure 37. Mean changes in the B Point to Na-Perp Distance during phase one 
(1) and phase two (2) of compound orthodontic treatment, by sex. 
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difference also decreased slightly during the fixed phase, to an average of 6.0 
mm at the end of treatment.  The Bionator effect, then, was to normalize the 
facial profile by advancing B Point more than inhibiting maxillary growth. 
 
Dental Changes 
Numerous, redundant measures of dental changes were calculated 
(Table 5) because the basic cephalometric analysis was borrowed from the 
Department’s clinical analysis.  Of some note, most of these 10 dental variables 
changed significantly more during the first, Bionator interval of treatment even 
though one supposes that there is greater control over tooth movement during 
the full-bonded appliance phase. 
 
Occlusal Plane 
Downs’ occlusal plane (measured to FH) did not change much during 
either phase of treatment (Figure 38), though there was an unanticipated sex 
difference (Table 6), with boys exhibiting a greater decrease (counterclockwise 
rotation) than girls.  On the other hand, the absolute differences are less than 2° 
in all groups. 
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Figure 38. Mean changes in the occlusal plane to FH angle during phase one (1) 
and phase two (2) of compound orthodontic treatment, by sex. 
 102 
Overjet, Overbite 
The expressions of overjet and overbite depend on both tooth and 
supporting bone positions, but are dealt with here because fixed treatment 
deals principally with repositioning the teeth themselves.  Overjet improved 
(diminished) an average of 3.1 mm in these retrognathic cases over the course 
of treatment, but most of the correction (3.0 mm, or 97%) occurred during the 
Bionator phase (Figure 39).  Overbite moved from a mean of 3.7 mm to 1.7 mm 
at the end of treatment, an overall change (reduction) in overbite of 1.9 mm.  
Most of this change (95%) occurred during the Bionator phase of treatment 
(Figure 40).  Statistically, overjet and overbite both improved far more during 
the earlier phase.  For those children with unaesthetic incisor relationships, 
these corrections years earlier than with conventional treatment should be seen 
as beneficial. 
 
Maxillary Incisor 
The upper incisor was proclined, from a mean of 23º to 27º during 
treatment (i.e., U1 to Nasion-A Point angle).  Statistically, there was no 
difference in the amount of change between the two phases.  There is no 
obvious explanation for the observed sex difference (Figure 41), but the typical 
boy underwent appreciably—and statistically significantly—more U1  
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Figure 39. Mean changes in incisor overjet during phase one (1) and phase two 
(2) of compound orthodontic treatment, by sex. 
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Figure 40. Mean changes in Incisor Overbite during phase one (1) and phase 
two (2) of compound orthodontic treatment, by sex. 
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Figure 41. Mean changes in the U1 to Nasion A Point angle during phase one 
(1) and phase two (2) of compound orthodontic treatment, by sex. 
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proclination during treatment compared to the girls who characteristically 
underwent U1 uprighting as measured from Nasion-to-A Point. 
The maxillary central incisor also was measured relative to the Nasion-A 
Point line, both angularly and millimetrically.  Angularly, U1 changed more 
during the Edgewise phase, but the changes are made complex by the 
significant sexual dimorphism (Figure 41; Table 5).  Boys typically experienced 
incisor proclination; girls typically experienced incisor uprighting.  These sex 
differences were evident during both phases of treatment (Figure 42).  For the 
total two-phase sample, the incisal edge of U1 started 3.0 mm from the Nasion-
A Point line, and treatment was completed with U1 4.4 mm from this line. 
Interincisal angle exhibited no difference in the amounts of change 
between phases (Table 5), but there was a highly significant sex difference 
(Figure 43).  The angle decreased on the order of 3º to 4º during each phase in 
boys; this angle increased about 3º during each phase in girls. 
The mandibular incisor angle to the A-Pogonion line increased during 
treatment (Figure 44), but the amount of dental change is affected by 
uprighting of the A-Pogonion line as the retrognathia was alleviated.  Still (as 
with comparison to IMPA), it is evident that the lower incisor experienced 
some proclination.  Statistically, this angular change (L1 proclination) was 
significantly greater during the Bionator phase of treatment.  Assessing the L1 
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Figure 42. Mean changes in the U1 to Na A Point (mm) during phase one (1) 
and phase two (2) of compound orthodontic treatment, by sex. 
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Figure 43. Mean changes in the interincisal angle during phase one (1) and 
phase two (2) of compound orthodontic treatment, by sex. 
 109 
 
 
Figure 44. Mean changes in the L1 to A Pogonian angle during phase one (1) 
and phase two (2) of compound orthodontic treatment, by sex. 
 110 
to A-Pogonion line millimetrically (Figure 45) also disclosed a sex difference—
greater L1 proclination in boys—as well as the greater change during the first, 
Bionator phase of treatment. 
The L1 to Nasion-B Point changes (Tables 5, 6) also need to be viewed 
with an appreciation for the alleviation of mandibular retrognathia (and, 
thereby, uprighting of the Nasion-B Point line).  Still, the improvement during 
treatment—and the sex differences seen in the prior variables—were evident 
here as well (Figures 46, 47).  There was a net uprighting of L1 with its incisal 
edge being moved back (distally) relative to the Nasion-B Point line. 
IMPA often is scrutinized with some care, largely because of claims that 
L1 is more stable when upright over basal bone (Riedel 1960; Joondeph and 
Riedel 1994).  In this sample, IMPA changed to different extents during the two 
phases and also differently between boys and girls (Table 6).  Overall, IMPA 
began at a mean of 94º, increased to a mean of 96º at the end of Bionator 
treatment, and then decreased slightly to an average of 95º at the end of 
treatment.  Figure 48 shows that little change (ca. 1º) was observed on the 
average in either phase in the boys; girls also changed little during phase 1 (ca. 
1º), but then uprighted almost 4º during the Edgewise phase. 
FMIA—a key measure of change in the maxillary central incisor—
comparably exhibited little change is boys (Figure 49), but there was about 4º of 
labial crown tipping during the Edgewise phase in girls. 
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Figure 45. Mean changes in the L1 to A Pg (mm) during phase one (1) and 
phase two (2) of compound orthodontic treatment, by sex. 
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Figure 46. Mean changes in the L1 to Nasion B Point angle during phase one 
(1) and phase two (2) of compound orthodontic treatment, by sex. 
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Figure 47. Mean changes in the L1 to Na B Point (mm) during phase one (1) 
and phase two (2) of compound orthodontic treatment, by sex. 
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Figure 48. Mean changes in the IMPA during phase one (1) and phase two (2) 
of compound orthodontic treatment, by sex. 
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Figure 49. Mean changes in the FMIA during phase one (1) and phase two (2) 
of compound orthodontic treatment, by sex. 
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Timing of Orthodontic Correction 
 
While a bit redundant, we can summarize the changes during the two 
phases of treatment in Figure 50.  One expected advantage to early intervention 
of a developing malocclusion is that the correction is achieved at an earlier age, 
so some or most of the esthetic improvement occurs earlier.  Consequently, the 
merit of this approach depends on how much of the overall skeletodental 
improvement occurs in the earlier, functional phase of treatment.  This was 
evaluated here by calculating the change occurring during the Bionator versus 
the later fixed phase of treatment. 
Roughly half of the correction in lower facial profile (Z angle, E plane) 
occurred during each phase of treatment.  Also, about half the decrease in NAP 
occurred in each phase.  Almost all of the correction in the lower facial profile 
(i.e., increase in SNB, decrease in ANB, decrease in AOBO, increase in facial 
angle, and forward growth of B Point) occurred during the Bionator phase of 
treatment. 
Dentally, most of the overall correction also was achieved prior to 
treatment with fixed appliances.  This is obvious (Figure 50) for the changes in 
interincisal angle, U1 to A Point distance, overjet, and overbite. 
Of note, the maxillary skeletal correction (a decrease in SNA averaging 
1.5° and a decrease in A Point to Na-perpendicular averaging 1.1 mm) occurred 
almost wholly during the later, Edgewise phase, but these overall changes are  
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Figure  50.  Changes during the two phases of treatment. 
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averaging 1.6° and an increase in B Point to Na- perpendicular averaging 2.6 
mm) were products of the Bionator phase of treatment. 
Net treatment depends on both phases, and none of these cases was 
treated without conventional fixed appliances, but these results suggest that 
several aspects of the malocclusion are addressed at a younger age in the two-
phase modality, which may be pertinent as regards to (A) the child’s self 
perception of his dental esthetics and (B) reducing the severity of the occlusal 
issues that need to be corrected with fixed appliances. 
 
End of Treatment 
The most informative aspect of this study, certainly from the clinician’s 
perspective, is the comparison between the cephalometric results of the two 
treated methods at the end of treatment.  It can be argued that the merit of any 
treatment method needs to be judged by how satisfactory the end result is. 
Two tables show the end result of treatment.  Table 7 lists the sample 
means (primarily so they are at hand here), and Table 8 lists the results of 
mixed model ANOVAs testing for between-group differences while controlling 
for any sexual dimorphism in size of the variable (Winer et al. 1991). 
Table 8 shows that eight of the cephalometric variables are frankly 
significant statistically (P < 0.05), while some others are suggestive (0.10 > P > 
0.05). 
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We can begin with the NAP angle (Downs’ angle of convexity).  This 
angular measure of facial convexity was significantly better (i.e., smaller) in the 
two-phase group.  The angle averaged 2.7º in the two-phase group compared 
to a mean of 4.8º in the single-phase group.  That is, the two-phase group, on 
the average, achieved a more orthognathic facial profile (Figure 51).  Table 8 
shows that there is also a significant sex difference in the terminal NAP 
relationship, with males having a straighter profile (i.e., a smaller mean angle) 
than the girls. 
ANB, a complementary measure of maxillomandibular relationship 
(parasagittally), also exhibited a highly significant difference at the end of 
treatment (Table 8; Figure 52).  ANB was significantly smaller ( x  = 2.6°) in the 
two-phase group than in the one-phase group ( x  = 3.7°).  This is of interest 
because the mean ANB was quite comparable between groups at the start of 
treatment, even when adjusting for the differences in the starting ages.  Both 
samples had a mean ANB jaw discrepancy of about 5.5° at the start of 
treatment. 
The AOBO discrepancy is another key measure of parasagittal jaw 
relationship.  This comparison is made complex by different starting conditions 
(Figure 53).  This was not a variable we matched the cases on, and the average 
AOBO was greater in the conventional Edgewise sample (mean of 2.0 vs. 0.5 
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Figure 51. Histogram of group averages for NAP angle evaluated at the end of 
treatment.  Error bars are 95% confidence limits. 
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Figure 52. Histogram of group averages for ANB angle evaluated at the end of 
treatment.  Error bars are 95% confidence limits. 
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Figure 53. Histogram of group averages for AOBO evaluated at the end of 
treatment.  Error bars are 95% confidence limits. 
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mm), perhaps because the one-phase sample was treated at an older age and 
the malocclusion had gotten worse.  The AOBO discrepancy was significantly 
worse at the end of treatment (Table 8; P < 0.0001) in the one-phase sample, 
but, again, it likewise was significantly worse at the start of treatment. 
These comparisons merit reflection:  The two measures of jaw 
relationships based on the basal bone relationships (NAP, ANB) show that 
mandibular growth was enhanced in the two-phase sample, whereas AOBO—
which depends more on dentoalveolar relationships—is not as fully resolved 
with the one-phase strategy (Table 8), perhaps because the discrepancy had 
gotten too entrenched at the older age of treatment. 
 
Facial Profile 
One simple perspective found in the specialty is that two-phase 
treatment resolves the inter-jaw discrepancy by moving B Point (i.e., the 
mandible) forward, while conventional one-phase treatment achieves the 
correction primarily by restraining A Point (i.e., the maxilla).  This was 
investigated here by looking at the distance of A and B Points, respectively, 
measured to Nasion-Perpendicular (Table 8).  Supposing that these are indeed 
discriminating variables, there was no statistical difference in either distance at 
the end of treatment (Figures 54, 55).  The descriptive statistics in Table 7 show 
that A and B Points are slightly better aligned vertically in the two-phase 
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Figure 54. Histogram of group averages for A Point to Nasion-Perpendicular 
evaluated at the end of treatment.  Error bars are 95% confidence limits. 
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Figure 55. Histogram of group averages for B Point to Nasion-Perpendicular 
evaluated at the end of treatment.  Error bars are 95% confidence limits. 
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group, but this has already been confirmed by the analysis of NAP and ANB. 
These previous paragraphs focus attention on the few but critical 
skeletodental differences between groups (Table 8), but it is at least as valuable 
to consider the several variables for which both treatment protocols achieve the 
same end points. 
In lateral view, the two integumental variables (E Plane, Z angle) 
achieved the same end point (Figures 56, 57).  It would, of course, be valuable 
to know how these two variables progress as the adolescents age, and the nose 
and chin grow forward. 
Average SNA and SNB angles both arrived at the same points 
statistically (Figures 58, 59).  Again, though, these two angles obscure the 
statistically significant difference of about 1° in the ANB angle, where the two 
phases of treatment more fully resolved the inter-arch discrepancy. 
Dentally, highly significant differences are seen for U1 relative to the 
Nasion-A Point line, because U1 was significantly behind (more distal to the 
Nasion-A Point line) in the two-phase sample (Figures 60, 61).  This, however, 
is a consequence of operator preference. 
Several key dental variables were treated to the same end points.  Of 
note here, the group measures for IMPA (Figure 62), FMIA (Figure 63), and the 
interincisal angle (Figure 64) were virtually identical in the two groups at the 
end of treatment.  Both treatments also achieved statistically the same positions 
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Figure 56. Histogram of group averages for E Plane evaluated at the end of 
treatment.  Error bars are 95% confidence limits. 
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Figure 57. Histogram of group averages for Z angle evaluated at the end of 
treatment.  Error bars are 95% confidence limits. 
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Figure 58. Histogram of group averages for SNA evaluated at the end of 
treatment.  Error bars are 95% confidence limits. 
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Figure 59. Histogram of group averages for SNB angle evaluated at the end of 
treatment.  Error bars are 95% confidence limits. 
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Figure 60. Histogram of group averages for U1 to Nasion-A Point angle 
evaluated at the end of treatment.  Error bars are 95% confidence limits. 
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Figure 61. Histogram of group averages for U1 to Nasion-A Point (mm) 
evaluated at the end of treatment.  Error bars are 95% confidence limits. 
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Figure 62. Histogram of group averages for IMPA evaluated at the end of 
treatment.  Error bars are 95% confidence limits. 
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Figure 63. Histogram of group averages for FMIA evaluated at the end of 
treatment.  Error bars are 95% confidence limits. 
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Figure 64. Histogram of group averages for interincisal angle evaluated at 
the end of treatment.  Error bars are 95% confidence limits. 
 140 
were virtually identical in the two groups at the end of treatment.  Both 
treatments also achieved statistically the same positions of the mandibular 
central incisor as regards to the Nasion-A Point line (Figures 65, 66) and the 
Nasion-B Point line (Figures 67, 68). 
Overjet ended up at just over 3 mm in both treatments (Figure 69), but 
overbite was significantly different (Figure 70).  Overbite averaged 1.2 mm in 
the one-phase series but was significantly deeper (P = 0.002) at an average of 
1.8 mm in the two-phase series.  Again, though, this difference is due to 
operator preference; the minor differences in incisor relationships were 
intended to provide better disclusion in the two-phase group. 
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Figure 65. Histogram of group averages for L1 to A-Pogonion angle evaluated 
at the end of treatment.  Error bars are 95% confidence limits. 
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Figure 66.  Histogram of group averages for L1 to A-Pogonion (mm) 
evaluated at the end of treatment.  Error bars are 95% confidence limits. 
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Figure 67. Histogram of group averages for L1 to Nasion-B Point angle 
evaluated at the end of treatment.  Error bars are 95% confidence limits. 
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Figure 68. Histogram of group averages for L1 to Nasion-B Point (mm) 
evaluated at the end of treatment.  Error bars are 95% confidence limits. 
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Figure 69. Histogram of group averages for incisor overjet evaluated at the end 
of treatment.  Error bars are 95% confidence limits. 
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Figure 70. Histogram of group averages for incisor Overbite evaluated at the 
end of treatment.  Error bars are 95% confidence limits. 
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CHAPTER V 
 
DISCUSSION 
 
The prevalence of Class II malocclusions among children in the United 
States is approximately 15% (Kelly and Harvey 1977), and there are, broadly, 
two approaches in use today to treat these cases.  The conventional approach is 
to wait until the early permanent dentition has emerged, then use full-bonded 
fixed appliances to treat the malocclusion in a single phase.  Alternatively, the 
child can be treated with a functional appliance in the mixed dentition, 
followed by a second phase of fixed treatment.  There are proponents (and 
vocal opponents) to each of these approaches.  Results of influential 
randomized clinical trials (O’Brien 2003; Tulloch et al. 2004; King et al. 2003) 
uniformly show that there is no benefit from two-phase treatment, yet other 
publications tout the merits of early intervention rather convincingly.  The 
purpose of this study was to compare the skeletodental outcomes of two 
samples matched for difficulty of the Class II malocclusion, one sample treated 
with a Bionator in the mixed dentition (followed by Edgewise treatment) and 
the other treated with Edgewise mechanics alone in the permanent dentition. 
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Time in Treatment 
The present study found that the one-phase group had a mean time in 
treatment of 2.8 years compared to 4.2 years for the two-phase group.  Overall 
clock time, then, was 1.4 years longer for the two-phase group.  These findings 
agree with those of Bremen and Pancherz (2002) who studied the efficiency of 
early and late Class II division 1 treatment.  They noted that patients treated 
exclusively with fixed appliance had a shorter duration than did patients 
treated with functional appliances or a combination of appliances (38 months 
for functional appliances and 49 months for a combination).  These data also 
agree with those of Livieratos and Johnston (1995) who studied a two-stage 
Bionator-Edgewise regimen in comparison to a conventional one-stage 
Edgewise treatment in a “matched” Class II sample.  This argument, that there 
is a difference in clock time, hardly warrants intense investigation since it is 
obvious.  Intuitively, two phases of treatment with an earlier starting age ought 
to take a longer time than a single phase of treatment.  Livieratos and Johnston 
(1995) observed that in addition to taking 18 months longer, the two-stage 
treatments averaged 10 more appointments.  However, the overall 
appointment rate (13 per year) was lower than for the single-phase Edgewise 
group (17 per year).  This difference was attributed to fewer appointments, 
with a more “leisurely” pace during the functional phase of treatment.  Similar 
findings also were noted by Tulloch et al. (2004).  In the current study, Bionator 
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patients were seen every 2 months with minor chair time per appointment 
during phase 1.  It was the opinion of the specialist who treated these cases that 
(1) appointments required very little of his time during the Bionator phase and 
(2) the younger children were well motivated and compliant. 
It is logical that if early treatment reduced the complexity of later 
treatment, there should be a reduction in phase 2 treatment time and, as well, a 
reduction in the need for premolar extractions.  In a study of early Class II 
treatment outcomes, Tulloch et al. (2004) noted that comprehensive treatment 
took as long in children who had early treatment than in those who did not.  
They also noted that early treatment did not reduce the need for extractions or 
surgery.  In the present study, overall time spent in Edgewise appliances for 
the two-phase group was 7 months shorter than in the one-phase treatment.  In 
addition, the two-phase group had a much lower percentage of extractions, 
12% for the two-phase group compared to 84% for the one-phase group.  
Complexity of treatment was reduced in the two-phase subjects in so far as 
there were far fewer extractions and the second phase of treatment was shorter. 
Complaints from opponents about longer time in treatment may, 
however, be a red herring.  It seems at least as pertinent to ask (1) when (at 
what age) does the bulk of the skeletodental correction occur (because this 
affects the child’s perception of his esthetics) and (2) is the final result 
demonstrably better?  These two issues are discussed below. 
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Extraction Treatment 
It is not clear how to value the preservation of all eight premolars in the 
two-phase sample.  Two-phase treatment substantially decreases chances that 
teeth need to be extracted, but so what?  Preservation of a full dentition does 
not seem to affect masticatory efficiency.  Other than the perception that 
extractions are “wrong” and parents may want their children to be treated 
without extractions, there seems to be no scientific basis for preferring the 
retention of all premolars.  There may be gnathological reasons to prefer an 
intact dentition, but this does not seem to be documented.  There is, however, 
another consideration that often seems to be under-valued by the orthodontist.  
The compelling reason most adolescents (and their parents) seek treatment is to 
improve their dental esthetics (e.g., Shaw et al. 1980, 1981; O’Brien et al. 1996).  
There are at least two interrelated issues here.  One, early intervention 
improves the esthetic aspects of the malocclusion at an earlier age.  As 
discussed previously, much of the skeletal and dental improvement occurs 
during the Bionator phase of treatment (Figure 50).  In the present situation, 
this means that much of the over-all improvement has been achieved by 11 to 
12 years of age versus about 16 years of age with conventional treatment (Figure 
71).  Two-phase treatment is a means of reducing the psychosocial stresses 
associated with malocclusions (Mandall et al. 2005) and promoting self esteem 
(Birkeland et al. 2000). 
 151 
 
Figure 71.  Histogram showing treatment times in years.  On the downside, 
two-phase treatment obviously does take longer, even allowing for the “gap” 
between the two stages.  On the other hand, much of the skeletodental 
correction is achieved during the Bionator phase, which ought to improve the 
child’s self perception of his facial esthetics earlier.  Also, it may be 
consequential to the patient that treatment is finished around 14 instead of 
around 16 years of age.  This means that, on average, the patient is out of 
treatment when a freshman in high school instead of a junior. 
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In a similar vein, it has been commented that conventional orthodontics, 
started in the early permanent dentition, may well be the only situation where 
the health care provider intentionally allows the problem (the malocclusion) to 
develop to its severest form before initiating treatment.  In concept, it would 
seem easier for the specialist and the patient to resolve the esthetic problem 
before it is full blown. 
This is particularly true for severe problems as noted by Tulloch et al. 
(2004).  Overjet is a case in point.  The permanent incisors emerge between 
about 6 and 8 years of age (van der Linden and Duterloo 1976), which 
Broadbent (1937) has noted is the beginning of the “ugly duckling” stage of the 
mixed dentition.  Studies show that the greater the overjet, (1) the greater the 
risk of trauma to these teeth (Schopf 2003; Karaiskos et al. 2005) and (2) the 
greater the esthetic disability (Brook and Shaw 1989).  Additionally, most 
trauma to the incisors occurs before age 10, so conventional treatment at 12 or 
13 years, occurs after the interval of greatest risk. 
 
Patterns of Skeletodental Change 
During the first phase of treatment in the two-phase group, most of the 
variables tested (16/28) exhibited significant changes.  The data suggest that 
the mandible achieved a less retrognathic relationship during phase 1.  NAP 
decreased on average 3.4°, ANB was reduced on average 1.5°, and AOBO 
 153 
decreased on average 2.3 mm.  Similar findings have been reported by other 
studies.  Heij and others (1989) investigated the skeletal and dentoalveolar 
effects of the Bionator on Class II malocclusions and reported an average 
decrease in ANB of 1.9º.  Lange (1995) compared the effects of the Bionator on 
Class II subjects to an untreated control group.  With the Bionator,  SNB 
increased 1.0º while ANB was reduced 1.9º.  Almeida et al. (2002) investigated 
the treatment effects of the Fränkel and Bionator appliances on Class II 
malocclusions and compared them to an untreated control group.  The 
Bionator group exhibited an average increase in SNB of 1.4º and an average  
reduction in ANB of 1.4º.  NAP was reduced by 2.8º.  Tulloch et al. (2004) 
observed a mean annualized reduction in ANB of 0.9° for early Class II 
treatment with the Bionator.  Jena et al. (2006) in a comparative study of the 
treatment effects of the Twin-block and Bionator appliances on Class II 
malocclusions reported an average reduction of 1.5º in ANB for the individuals 
treated with the Bionator. 
It has been argued that functional appliance therapy corrects skeletal 
disharmonies mainly through an improvement in mandibular position in 
relation to the cranial base instead of the restriction of maxillary growth.  
Indeed, in the current study, the reduction in ANB was achieved mainly during 
the Bionator phase due to an increase in SNB (1.7º).  There was a subsequent 
decrease in SNA (1.2º) during fixed appliance treatment.  ANB improved 
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(decreased) significantly more in phase 1 ( x  = -1.9º) than in phase 2 ( x  = -1.1º).  
Janson (1987) reported similar findings with a group of 35 individuals treated 
with Bionator therapy compared to 99 individuals treated with fixed 
appliances.  The Bionator group achieved a reduction in ANB mainly through 
an increase in SNB.  The fixed appliance group achieved ANB correction 
mainly through a reduction in SNA.  Tulloch et al. (2004) also found an initial 
reduction in ANB (-0.9º) after phase 1 mainly through an increase in SNB (1.1º) 
in their Bionator sample.   
We also measured A and B points relative to Nasion-Perpendicular.  A 
Point changed almost not at all during Bionator treatment, but B Point grew 
forward an average of 2.7 mm during the first phase of treatment.  These 
findings are similar to Tulloch and others (2004) who reported a change of 0.1 
mm for A Point relative to Nasion-Perpendicular and 1.1 mm for Pogonion 
relative to Nasion-Perpendicular after an initial phase of Bionator treatment. 
 
Patterns of Dentoalveolar Change 
Most of the 10 dental variables changed significantly more during the 
Bionator treatment even though one would suppose that there is greater 
control over tooth movement with fixed appliances.  Overjet improved an 
average of 3.1 mm during the course of treatment, but 3.0 mm or 97% of this 
occurred during the initial phase of treatment.  Overbite changed from 3.7 mm 
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to 1.7 mm with 95% of the change occurring again during Bionator treatment.  
Bolmgren (1986), Lange (1995), Illing (1998), and Tulloch et al. (2004) all showed 
a similar pattern of overbite and overjet reduction after an initial phase of 
Bionator therapy in Class II malocclusions.  It should again be noted that in the 
current study, most of the overjet and overbite correction was achieved at an 
early age during the first phase of treatment.  It should not be overlooked that 
for children with unaesthetic incisor relationships, these early corrections 
should be seen as beneficial. 
Numerous studies have shown that functional appliances produce 
excessive labial tipping of the lower incisors as well as an uprighting of the 
upper incisors (Illing 1998; Almeida et al. 2002, 2004).  The upper incisor was 
proclined from a mean of 23ºto 27º during treatment (U1 to Nasion-A Point 
angle) in the present study.  However, there was no difference in the amount of 
change between the two phases.  IMPA changed very little (ca. 1º) during the 
initial phase of treatment.  These findings agree with those reported by 
Bolmgren et al. (1986) and Lange (1995) who found virtually no change in lower 
incisor position after Bionator treatment.  However, Illing (1998) and Almeida 
et al. (2002) measured an average of 2 to 4º of labial tipping of the lower incisors 
after an initial phase of Bionator treatment.  As previously mentioned, in the 
present study the lower incisors were not significantly proclined during the 
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first phase of treatment, and were uprighted roughly 4º during the Edgewise 
phase. 
 
End of Treatment 
The most informative aspect of this study is the comparison between the 
cephalometric results of the two treated methods at the end of treatment. 
One strong motivation to “bother” with an early functional phase of 
treatment is to improve the Class II, convex facial profile using some sort of 
hyperpropulsion device.  The present study was not designed to address the 
question of whether the Bionator increased mandibular length over that 
expected from growth alone (Meikle 2007).  Instead, we simply evaluated the 
bony facial profile at the end of treatment in the two groups.  We focus here on 
five measures of the bony profile, namely (1) NAP angle, (2) SNA angle, (3) 
SNB angle, (4) ANB angle, and (5) the AOBO discrepancy.  We matched the 50 
two-and one-phase cases on the first four of these, and include AOBO here for 
completeness.  Figures 72 through 76 are plots of the group means for these 
variables at the start and end of treatment, and the figure legends list the 
results of paired t-tests. 
Facial convexity (the NAP angle) is significantly smaller in the two-
phase sample (Figure 72).  Neither SNA nor SNB is statistically different 
between the samples at the end of treatment, but there was a significantly 
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Figure 72. Plot of mean NAP angle at the start and end of treatment in the two 
groups (sexes pooled). By paired t-test, there was no difference between the 
two groups at the start of treatment (t = 0.25; P = 0.8012), but the difference was 
significant at the end of treatment (t = 2.46; P = 0.0173).  
Mean Value (degrees)  
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 Figure 73. Plot of mean AOBO discrepancy at the start and end of treatment in 
the two groups (sexes pooled). By paired t-test, there was a significant 
difference between the two groups at the start of treatment (t = 3.35; P = 0.0016) 
and at the end of treatment (t = 3.46; P = 0.0011). The samples were not 
matched on this variable. 
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 Figure  74. Plot of mean SNA angle at the start and end of treatment in the two 
groups (sexes pooled). By paired t-test, there was no difference between the 
two groups at the start of treatment (t = 0.33; P = 0.7454) nor at the end of 
treatment (t = 0.09; P = 0.9265). 
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 Figure 75. Plot of mean SNB angle at the start and end of treatment in the two 
groups (sexes pooled). By paired t-test, there was no difference between the 
two groups at the start of treatment (t = 0.58; P = 0.5652) nor at the end of 
treatment (t = 1.63; P = 0.1088). 
 161 
 Figure 76. Plot of mean ANB angle at the start and end of treatment in the two 
groups (sexes pooled). By paired t-test, there was no difference between the 
two groups at the start of treatment (t = 1.13; P = 0.2601), but the difference was 
highly significant at the end of treatment (t = 3.73; P = 0.0005). 
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greater improvement (reduction) of the ANB angle in the two-phase sample 
(Figure 75).  The AOBO discrepancy improved (was reduced) in both samples, 
but to equivalent degrees (Figure 76). 
We do not know yet whether these improvements in the facial profile 
are perceptible upon viewing the patients, but these cephalometric values 
suggest that the Bionator phase of treatment produced a statistically significant 
improvement at the end of treatment compared to Edgewise treatment alone. 
We cannot ascertain from this study how the greater improvement in 
NAP and ANB were achieved.  That is, it is clear that the change was due to a 
mesial movement of the mandible (B Point) rather than retraction of the maxilla 
(A Point), because SNA was reduced about 1.5º in both groups (P = 0.4896).  
We cannot specify how the forward movement of B Point occurred.  It could 
have resulted from (A) mandibular growth, (B) forward remodeling of the 
glenoid fossa, (C) counterclockwise rotation of the temporal bone (hard to 
conceive but speculated in the literature), (D) restriction of growth in the 
spheno-occipital synchondrosis in the Bionator group, or (E) some undefined 
combination of these several effects.  Statistical analysis shows that, whatever 
the mechanism, significantly more of the change in SNB, the facial angle (Na-
Pg to FH), and B Point relative to Nasion-Perpendicular occurred during the 
Bionator phase of treatment. 
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It might be argued that improvement in the facial profile is just postural, 
that the Bionator simply caused the subjects to “bite forward.”  This is most 
unlikely because (1) the improvement occurred primarily in phase 1, (2) the 
Bionator was removed before phase 2, and (3) the subjects had an average of 
2.2 years (27 months) of Edgewise treatment during which relapse could have 
occurred.  Instead of any relapse, ANB and the facial angle continued to 
improve (decrease) during the Edgewise phase of treatment.  Inspection 
suggests (Figure 50) that, in fact, B Point came forward a little bit more during 
the Edgewise phase, and that most of the continued improvement was 
accomplished by a reduction (restraint) of A Point, which is characteristic of 
fixed appliance therapy.  The net result, however, is that the 2.2 years of fixed 
appliance treatment afforded ample opportunity for any mandibular relapse to 
occur, and none was seen. 
 
Dentition and Integument 
Of the dental variables measured, upper incisor position differed 
between the two groups at the end of treatment.  The interincisal angle was 
slightly more acute in the two-phase group and the upper incisor was more 
proclined by an average of 5º (U1 to Nasion-A Point angle).  The explanation 
for this difference is operator preference.  The orthodontist who treated the 
two-phase cases prefers to finish them with this type of incisor angulation for 
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improved anterior guidance and posterior disclusion in anterior excursive 
movements.  Interestingly, the interincisal angle and U1 to Nasion-A Point 
angle for the two-phase sample are virtually the same when compared to the 
values reported by Riolo et al. (1974) for normal untreated children—moreso 
than for the Edgewise sample. 
Both treatments achieved the same positions of the mandibular central 
incisor in regards to the Nasion-B Point line and IMPA.  The two integumental 
variables (E Plane, Z angle) achieved the same end points as well. 
What can be concluded is that both groups achieved similar dental 
measurements (with the exception of upper incisor position).  However, the 
two-phase group exhibited a more orthognathic bony facial profile at the end 
of treatment as shown by the changes in key skeletal variables (NAP, ANB, and 
AOBO). 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
There has been considerable discussion in the orthodontic literature 
regarding the biological and clinical advantages and disadvantages of “early” 
orthodontic intervention, specifically for Class II malocclusions.  Of primary 
concern is the benefit, or lack thereof, gained with regard to treatment 
outcomes when using a two-phase treatment protocol compared to one phase 
of treatment.  The present study compared two groups of patients, one treated 
with the Bionator appliance in the mixed dentition followed by full appliance 
treatment.  The second group was treated in a single phase with conventional 
Edgewise mechanics.  The question was whether the cephalometric results at 
the end of treatment were comparable. 
This study was a retrospective analysis of cephalograms from patients 
with Class II, division 1 malocclusions at the start of treatment.  These were 50 
consecutively treated youths who received phase 1 (early) treatment with a 
Bionator appliance and later treatment with full appliances (all treated by a 
single clinician).  The control group consisted of a sample of subjects with 
similar Class II, division 1 malocclusions who were treated in a single phase 
with fixed Edgewise appliances alone.  Importantly, the subjects in the two 
samples were matched, on a one-to-one basis, for demographic and 
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cephalometric variables to ensure comparability in the nature and severity of 
the malocclusions.  Major findings are: 
• Both groups achieved roughly the same endpoints with regard to the 
dentition and the soft tissues (e.g., E Plane).  The upper incisors, however, 
were slightly more proclined in the two-phase group, but this was 
intentional due to operator preference. 
• The two-phase group achieved a better bony facial profile compared to the 
control group.  NAP (angle of convexity) averaged 2.7º in the two-phase 
group compared to a significantly greater mean of 4.8º in the one-phase 
group.  Comparably, ANB was significantly smaller ( x  = 2.6°) in the two-
phase group than in the one-phase group ( x  = 3.7°). 
• The majority of the skeletal and dental correction in the Bionator group was 
achieved during the first phase of treatment.  Almost all of the correction in 
the lower facial profile (i.e., increase in SNB, decrease in ANB, decrease in 
AOBO, increase in facial angle, and forward growth of B Point) occurred 
during the Bionator phase of treatment.  Dentally, most of the overall 
correction also was achieved prior to treatment with fixed appliances.  This 
made the fixed-phase of treatment easier, and it may also have enhanced 
these adolescents’ self-perceptions of their dental esthetics at a substantially 
earlier age. 
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• The frequency of extractions was 12% (6/50 cases) in the two-phase group 
compared to 84% (42/50) in the one-phase group.  The long-term advantages 
of an intact dentition—if any—are unknown, but parents often have the 
perception that extractions are “bad” and unwarranted. 
• The skeletal discrepancy was resolved in the two-phase group mainly 
through the advancement of B Point.  Indeed, the reduction in ANB for the 
two phase group was achieved mainly during the Bionator phase with an 
increase in SNB (1.7º).  Conversely, the reduction in ANB in the one-phase 
group was achieved through the restriction of maxillary growth. 
• No relapse was evident after the first phase of treatment.  The Bionator was 
removed before phase 2, so subjects had an average of 2.2 years (27 months) 
of Edgewise treatment during which relapse could have occurred, but none 
was seen.  This argues for the long-term stability of the skeletal improvement 
in facial harmony. 
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Table A-1. Descriptive statistics for the two-phase sample evaluated at the start 
of treatment. 
 
 Variable  x  sd sem L2 L1 n 
Z angle 66.39 10.20 1.44 69.28 63.49 50 
E Plane -0.85 2.82 0.40 -0.04 -1.65 50 
Y-Axis angle 66.90 3.43 0.49 67.87 65.92 50 
NAP angle 9.84 4.09 0.58 11.00 8.67 50 
SNA angle 81.86 3.23 0.46 82.78 80.95 50 
SNB angle 76.23 3.30 0.47 77.16 75.29 50 
ANB angle 5.64 1.55 0.22 6.08 5.20 50 
AOBO 3.48 1.93 0.27 4.03 2.94 50 
FMA angle 26.02 5.75 0.81 27.65 24.39 50 
IMPA 94.46 6.60 0.93 96.33 92.58 50 
FMIA 59.52 8.08 1.14 61.82 57.23 50 
OP to FH angle 9.22 4.62 0.65 10.53 7.90 50 
U1 to SeNa angle 104.61 8.73 1.23 107.09 102.13 50 
Interincisal angle 127.76 13.08 1.85 131.48 124.05 50 
U1 to Na A Pt angle 22.75 8.20 1.16 25.08 20.42 50 
U1 to Na A Pt mm 3.01 3.17 0.45 3.91 2.10 50 
L1 to A Pg mm 0.32 2.65 0.37 1.07 -0.43 50 
L1 to A Pg angle 19.65 6.12 0.87 21.39 17.91 50 
L1 to Na B Pt angle 23.84 7.26 1.03 25.90 21.78 50 
L1 to Na B Pt mm 4.19 2.39 0.34 4.87 3.51 50 
Facial angle 84.37 4.15 0.59 85.54 83.19 50 
Mand Length 102.01 5.97 0.84 103.71 100.31 50 
Sella-to-A Point 82.47 4.45 0.63 83.74 81.21 50 
Sella-to-B Point 101.37 5.48 0.78 102.93 99.81 50 
Overbite 3.67 2.17 0.31 4.29 3.05 50 
Overjet 6.43 2.03 0.29 7.01 5.85 50 
A Pt to Na-Perp -0.92 3.64 0.51 0.12 -1.95 50 
B Pt to Na-Perp -10.54 6.41 0.91 -8.72 -12.36 50 
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Table A-2. Descriptive statistics for the two-phase sample evaluated at the end 
of the Bionator phase of treatment. 
 
 Variable  x  sd sem L2 L1 n 
Z angle 71.31 8.94 1.28 73.88 68.74 49 
E Plane -2.48 2.33 0.33 -1.81 -3.15 49 
Y-Axis angle 66.90 3.43 0.49 67.89 65.92 49 
NAP angle 6.09 4.00 0.57 7.23 4.94 49 
SNA angle 81.54 3.02 0.43 82.40 80.67 49 
SNB angle 77.83 2.98 0.43 78.69 76.98 49 
ANB angle 3.70 1.49 0.21 4.13 3.27 49 
AOBO 0.92 2.10 0.30 1.53 0.32 49 
FMA angle 25.85 5.52 0.79 27.43 24.26 49 
IMPA 95.83 6.66 0.95 97.74 93.92 49 
FMIA 58.33 7.64 1.09 60.52 56.13 49 
OP to FH angle 8.32 4.05 0.58 9.48 7.15 49 
U1 to SeNa angle 104.70 6.08 0.87 106.45 102.95 49 
Interincisal angle 125.96 9.88 1.41 128.79 123.12 49 
U1 to Na A Pt angle 23.16 5.16 0.74 24.64 21.68 49 
U1 to Na A Pt mm 3.65 2.01 0.29 4.23 3.07 49 
L1 to A Pg mm 2.72 2.38 0.34 3.40 2.03 49 
L1 to A Pg angle 24.79 5.21 0.74 26.29 23.29 49 
L1 to Na B Pt angle 27.18 6.62 0.95 29.08 25.27 49 
L1 to Na B Pt mm 5.49 2.29 0.33 6.15 4.84 49 
Facial angle 86.31 3.80 0.54 87.40 85.22 49 
Mand Length 110.50 5.80 0.83 112.17 108.83 49 
Sella-to-A Point 85.65 4.04 0.58 86.81 84.49 49 
Sella-to-B Point 109.11 5.35 0.76 110.64 107.57 49 
Overbite 1.86 1.64 0.23 2.33 1.39 49 
Overjet 3.43 1.32 0.19 3.81 3.05 49 
A Pt to Na-Perp -0.82 3.34 0.48 0.14 -1.78 49 
B Pt to Na-Perp -7.66 6.21 0.89 -5.88 -9.45 49 
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Table A-3. Descriptive statistics for the two-phase sample evaluated at the end 
of the fixed phase of treatment. 
 
 Variable  x  sd sem L2 L1 n 
Z angle 73.85 8.50 1.20 76.26 71.43 50 
E Plane -4.13 2.55 0.36 -3.40 -4.85 50 
Y-Axis angle 67.31 3.37 0.48 68.27 66.36 50 
NAP angle 2.72 4.28 0.60 3.94 1.50 50 
SNA angle 80.39 3.19 0.45 81.30 79.49 50 
SNB angle 77.82 3.16 0.45 78.71 76.92 50 
ANB angle 2.58 1.59 0.23 3.03 2.13 50 
AOBO 0.55 2.39 0.34 1.22 -0.13 50 
FMA angle 25.39 5.64 0.80 27.00 23.79 50 
IMPA 94.62 6.47 0.92 96.46 92.78 50 
FMIA 59.99 7.22 1.02 62.04 57.94 50 
OP to FH angle 7.37 4.40 0.62 8.62 6.12 50 
U1 to SeNa angle 106.98 6.61 0.93 108.86 105.10 50 
Interincisal angle 125.31 9.82 1.39 128.10 122.52 50 
U1 to Na A Pt angle 26.58 6.07 0.86 28.31 24.86 50 
U1 to Na A Pt mm 4.40 2.29 0.32 5.05 3.75 50 
L1 to A Pg mm 2.27 2.34 0.33 2.93 1.60 50 
L1 to A Pg angle 25.37 5.01 0.71 26.79 23.95 50 
L1 to Na B Pt angle 25.52 5.81 0.82 27.17 23.87 50 
L1 to Na B Pt mm 4.86 2.36 0.33 5.53 4.19 50 
Facial angle 86.78 3.97 0.56 87.91 85.65 50 
Mand Length 114.46 6.77 0.96 116.38 112.54 50 
Sella-to-A Point 87.08 4.52 0.64 88.37 85.80 50 
Sella-to-B Point 112.30 6.16 0.87 114.05 110.55 50 
Overbite 1.75 0.94 0.13 2.02 1.49 50 
Overjet 3.30 0.71 0.10 3.50 3.10 50 
A Pt to Na-Perp -2.01 3.99 0.56 -0.87 -3.14 50 
B Pt to Na-Perp -7.96 6.73 0.95 -6.04 -9.87 50 
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Table A-4. Descriptive statistics for the changes during the Bionator (phase 1) 
of treatment. 
 
 Variable  x  sd sem L2 L1 n t-test P-Value 
Z angle 4.98 5.50 0.79 6.56 3.40 49 6.34 <0.0001 
E Plane -1.71 2.12 0.30 -1.10 -2.32 49 -5.66 <0.0001 
Y-Axis angle -0.05 1.18 0.17 0.28 -0.39 49 -0.32 0.7535 
NAP angle -3.72 2.45 0.35 -3.01 -4.42 49 -10.62 <0.0001 
SNA angle -0.24 1.36 0.19 0.15 -0.63 49 -1.24 0.2219 
SNB angle 1.69 1.40 0.20 2.09 1.28 49 8.40 <0.0001 
ANB angle -1.93 1.23 0.18 -1.58 -2.29 49 -11.04 <0.0001 
AOBO -2.53 2.44 0.35 -1.83 -3.23 49 -7.27 <0.0001 
FMA angle -0.18 1.46 0.21 0.25 -0.60 49 -0.84 0.4056 
IMPA 1.39 3.79 0.54 2.48 0.30 49 2.57 0.0133 
FMIA -1.21 3.84 0.55 -0.11 -2.31 49 -2.21 0.0323 
OP to FH angle -0.83 2.44 0.35 -0.14 -1.53 49 -2.40 0.0204 
U1 to SeNa angle -0.05 6.20 0.89 1.73 -1.83 49 -0.05 0.9579 
Interincisal angle -1.52 8.09 1.16 0.80 -3.85 49 -1.32 0.1936 
U1 to Na A Pt angle 0.18 6.12 0.87 1.94 -1.58 49 0.21 0.8382 
U1 to Na A Pt mm 0.57 2.06 0.29 1.16 -0.02 49 1.94 0.0577 
L1 to A Pg mm 2.32 1.56 0.22 2.77 1.87 49 10.43 <0.0001 
L1 to A Pg angle 5.05 4.10 0.59 6.23 3.88 49 8.63 <0.0001 
L1 to Na B Pt angle 3.27 3.79 0.54 4.36 2.18 49 6.05 <0.0001 
L1 to Na B Pt mm 1.25 1.38 0.20 1.65 0.86 49 6.35 <0.0001 
Facial angle 1.87 1.40 0.20 2.27 1.47 49 9.36 <0.0001 
Mand Length 8.68 3.60 0.51 9.71 7.64 49 16.89 <0.0001 
Sella-to-A Point 3.37 1.82 0.26 3.89 2.84 49 12.95 <0.0001 
Sella-to-B Point 7.92 2.79 0.40 8.72 7.12 49 19.86 <0.0001 
Overbite -1.75 1.98 0.28 -1.18 -2.32 49 -6.19 <0.0001 
Overjet -3.00 2.30 0.33 -2.34 -3.66 49 -9.12 <0.0001 
A Pt to Na-Perp 0.03 1.26 0.18 0.39 -0.33 49 0.16 0.8747 
B Pt to Na-Perp 2.74 2.15 0.31 3.35 2.12 49 8.94 <0.0001 
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Table A-5. Descriptive statistics for the changes during the second, fixed 
(Edgewise) phase of treatment. 
 
 Variable  x  sd sem L2 L1 n t-test P-Value 
Z angle 2.61 4.39 0.63 3.87 1.34 49 4.15 0.0001 
E Plane -1.66 1.70 0.24 -1.17 -2.15 49 -6.84 <0.0001 
Y-Axis angle 0.51 1.75 0.25 1.01 0.01 49 2.04 0.0472 
NAP angle -3.29 2.87 0.41 -2.47 -4.12 49 -8.03 <0.0001 
SNA angle -1.20 1.81 0.26 -0.68 -1.72 49 -4.63 <0.0001 
SNB angle -0.11 1.76 0.25 0.40 -0.61 49 -0.43 0.6698 
ANB angle -1.09 1.25 0.18 -0.73 -1.45 49 -6.09 <0.0001 
AOBO -0.35 2.40 0.34 0.34 -1.04 49 -1.02 0.3135 
FMA angle -0.43 1.88 0.27 0.11 -0.97 49 -1.61 0.1150 
IMPA -1.31 5.26 0.75 0.20 -2.82 49 -1.74 0.0882 
FMIA 1.73 5.22 0.75 3.23 0.23 49 2.31 0.0250 
OP to FH angle -1.01 2.92 0.42 -0.17 -1.85 49 -2.42 0.0194 
U1 to SeNa angle 2.00 6.04 0.86 3.73 0.27 49 2.32 0.0247 
Interincisal angle -0.45 8.58 1.23 2.01 -2.92 49 -0.37 0.7145 
U1 to Na A Pt angle 3.20 6.20 0.89 4.98 1.42 49 3.61 0.0007 
U1 to Na A Pt mm 0.74 2.28 0.33 1.40 0.09 49 2.28 0.0269 
L1 to A Pg mm -0.43 1.97 0.28 0.14 -0.99 49 -1.52 0.1347 
L1 to A Pg angle 0.53 4.99 0.71 1.97 -0.90 49 0.75 0.4567 
L1 to Na B Pt angle -1.66 4.85 0.69 -0.27 -3.06 49 -2.40 0.0203 
L1 to Na B Pt mm -0.60 1.77 0.25 -0.09 -1.10 49 -2.36 0.0225 
Facial angle 0.53 1.78 0.25 1.04 0.02 49 2.09 0.0421 
Mand Length 3.84 4.11 0.59 5.02 2.66 49 6.54 <0.0001 
Sella-to-A Point 1.29 2.43 0.35 1.99 0.59 49 3.71 0.0005 
Sella-to-B Point 3.07 3.51 0.50 4.08 2.07 49 6.13 <0.0001 
Overbite -0.10 1.69 0.24 0.38 -0.58 49 -0.41 0.6802 
Overjet -0.12 1.53 0.22 0.32 -0.56 49 -0.54 0.5910 
A Pt to Na-Perp -1.08 1.88 0.27 -0.54 -1.62 49 -4.03 0.0002 
B Pt to Na-Perp -0.19 3.11 0.44 0.71 -1.08 49 -0.42 0.6774 
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Table A-6. Descriptive statistics for the changes during treatment in the 
Edgewise (one phase) sample. 
 
 Variable  x  sd sem L2 L1 n t-test P-Value 
Z angle 7.46 6.48 0.92 9.30 5.62 50 8.14 <0.0001 
E Plane -3.28 2.42 0.34 -2.59 -3.97 50 -9.57 <0.0001 
Y-Axis angle 0.42 1.72 0.24 0.91 -0.07 50 1.71 0.0929 
NAP angle -7.12 3.32 0.47 -6.17 -8.06 50 -15.14 <0.0001 
SNA angle -1.47 2.10 0.30 -0.88 -2.07 50 -4.97 <0.0001 
SNB angle 1.59 1.68 0.24 2.07 1.11 50 6.68 <0.0001 
ANB angle -3.07 1.49 0.21 -2.64 -3.49 50 -14.58 <0.0001 
AOBO -2.94 2.89 0.41 -2.12 -3.76 50 -7.18 <0.0001 
FMA angle -0.63 2.18 0.31 -0.01 -1.24 50 -2.03 0.0474 
IMPA 0.16 6.04 0.85 1.88 -1.56 50 0.19 0.8521 
FMIA 0.46 5.96 0.84 2.16 -1.23 50 0.55 0.5860 
OP to FH angle -1.85 3.23 0.46 -0.93 -2.77 50 -4.04 0.0002 
U1 to SeNa angle 2.37 9.73 1.38 5.14 -0.39 50 1.73 0.0907 
Interincisal angle -2.46 13.00 1.84 1.24 -6.15 50 -1.34 0.1877 
U1 to Na A Pt angle 3.83 9.78 1.38 6.61 1.05 50 2.77 0.0079 
U1 to Na A Pt mm 1.39 3.33 0.47 2.34 0.44 50 2.95 0.0048 
L1 to A Pg mm 1.95 2.27 0.32 2.59 1.30 50 6.07 <0.0001 
L1 to A Pg angle 5.72 5.94 0.84 7.41 4.04 50 6.82 <0.0001 
to Na B Pt angle 1.68 5.62 0.79 3.28 0.08 50 2.11 0.0399 
L1 to Na B Pt mm 0.67 2.06 0.29 1.26 0.09 50 2.31 0.0253 
Facial angle 2.41 1.54 0.22 2.85 1.97 50 11.07 <0.0001 
Mand Length 12.45 3.80 0.54 13.53 11.37 50 23.17 <0.0001 
Sella-to-A Point 4.61 2.73 0.39 5.39 3.83 50 11.93 <0.0001 
Sella-to-B Point 10.93 3.65 0.52 11.97 9.89 50 21.16 <0.0001 
Overbite -1.92 2.02 0.29 -1.34 -2.49 50 -6.71 <0.0001 
Overjet -3.13 1.98 0.28 -2.57 -3.69 50 -11.17 <0.0001 
A Pt to Na-Perp -1.09 1.97 0.28 -0.53 -1.65 50 -3.91 0.0003 
B Pt to Na-Perp 2.58 2.73 0.39 3.36 1.81 50 6.68 <0.0001 
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Table A-7. Descriptive statistics for the Edgewise (one phase) sample at the 
start of treatment. 
 
 Variable  x  sd sem L2 L1 n 
Z angle 67.39 8.17 1.16 69.71 65.07 50 
E Plane -0.87 2.78 0.39 -0.08 -1.66 50 
Y-Axis angle 68.41 3.71 0.52 69.47 67.36 50 
NAP angle 9.70 4.61 0.65 11.01 8.39 50 
SNA angle 82.08 3.72 0.53 83.13 81.02 50 
SNB angle 76.61 3.31 0.47 77.55 75.67 50 
ANB angle 5.47 1.62 0.23 5.93 5.01 50 
AOBO 4.85 2.34 0.33 5.51 4.18 50 
FMA angle 26.71 6.49 0.92 28.56 24.87 50 
IMPA 94.99 7.02 0.99 96.99 93.00 50 
FMIA 58.29 6.19 0.87 60.04 56.53 50 
OP to FH angle 5.56 4.70 0.66 6.89 4.22 50 
U1 to SeNa angle 106.23 8.69 1.23 108.70 103.76 50 
Interincisal angle 123.29 10.77 1.52 126.35 120.23 50 
U1 to Na A Pt angle 24.14 8.19 1.16 26.47 21.81 50 
U1 to Na A Pt mm 4.33 3.28 0.46 5.26 3.40 50 
L1 to A Pg mm 1.50 2.81 0.40 2.30 0.70 50 
L1 to A Pg angle 22.86 5.13 0.73 24.32 21.40 50 
L1 to Na B Pt angle 27.09 6.04 0.85 28.81 25.38 50 
L1 to Na B Pt mm 5.45 2.68 0.38 6.21 4.69 50 
Facial angle 86.14 3.92 0.55 87.25 85.02 50 
Mand Length 113.02 6.14 0.87 114.77 111.28 50 
Sella-to-A Point 87.83 4.42 0.63 89.09 86.57 50 
Sella-to-B Point 109.59 6.10 0.86 111.32 107.86 50 
Overbite 2.99 2.61 0.37 3.73 2.25 50 
Overjet 6.94 2.53 0.36 7.66 6.22 50 
A Pt to Na-Perp 1.18 3.86 0.55 2.28 0.08 50 
B Pt to Na-Perp -7.60 6.46 0.91 -5.77 -9.44 50 
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Table A-8. Descriptive statistics for the Edgewise (one phase) sample at the end 
of treatment. 
 
 Variable  x  sd sem L2 L1 n 
Z angle 73.41 8.90 1.26 75.94 70.88 50 
E Plane -3.67 3.10 0.44 -2.79 -4.55 50 
Y-Axis angle 68.68 4.31 0.61 69.91 67.46 50 
NAP angle 4.75 5.12 0.72 6.20 3.30 50 
SNA angle 80.32 4.01 0.57 81.46 79.18 50 
SNB angle 76.61 3.85 0.54 77.71 75.52 50 
ANB angle 3.70 1.87 0.26 4.23 3.17 50 
AOBO 2.03 2.47 0.35 2.74 1.33 50 
FMA angle 26.35 6.19 0.88 28.11 24.59 50 
IMPA 94.04 6.55 0.93 95.90 92.18 50 
FMIA 59.61 7.63 1.08 61.78 57.44 50 
OP to FH angle 6.88 4.97 0.70 8.29 5.47 50 
U1 to SeNa angle 101.72 7.73 1.09 103.92 99.52 50 
Interincisal angle 128.85 8.65 1.22 131.31 126.40 50 
U1 to Na A Pt angle 21.40 7.00 0.99 23.39 19.41 50 
U1 to Na A Pt mm 2.56 2.26 0.32 3.20 1.92 50 
L1 to A Pg mm 1.12 2.68 0.38 1.88 0.35 50 
L1 to A Pg angle 24.99 4.98 0.70 26.40 23.57 50 
L1 to Na B Pt angle 26.04 6.52 0.92 27.89 24.19 50 
L1 to Na B Pt mm 4.61 2.85 0.40 5.42 3.80 50 
Facial angle 87.06 3.92 0.55 88.17 85.94 50 
Mand Length 118.80 7.38 1.04 120.90 116.70 50 
Sella-to-A Point 89.05 5.30 0.75 90.56 87.54 50 
Sella-to-B Point 113.28 6.53 0.92 115.14 111.43 50 
Overbite 1.17 1.24 0.18 1.52 0.82 50 
Overjet 3.50 1.35 0.19 3.88 3.11 50 
A Pt to Na-Perp -0.60 4.05 0.57 0.55 -1.76 50 
B Pt to Na-Perp -7.79 6.65 0.94 -5.90 -9.68 50 
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Table A-9. Descriptive statistics for the changes during treatment in the 
Edgewise (one phase) sample. 
 
 Variable  x  sd sem L2 L1 n t-test P-Value 
Z angle 6.01 7.41 1.05 8.12 3.91 50 5.74 <0.0001 
E Plane -2.79 2.44 0.34 -2.10 -3.48 50 -8.10 <0.0001 
Y-Axis angle 0.27 1.72 0.24 0.76 -0.22 50 1.11 0.2716 
NAP angle -4.95 4.11 0.58 -3.78 -6.12 50 -8.51 <0.0001 
SNA angle -1.75 2.19 0.31 -1.13 -2.38 50 -5.65 <0.0001 
SNB angle 0.00 1.83 0.26 0.52 -0.52 50 0.01 0.9939 
ANB angle -1.78 1.60 0.23 -1.32 -2.23 50 -7.87 <0.0001 
AOBO -2.81 3.29 0.47 -1.88 -3.75 50 -6.05 <0.0001 
FMA angle -0.36 2.38 0.34 0.31 -1.04 50 -1.07 0.2877 
IMPA -0.95 7.04 1.00 1.05 -2.95 50 -0.95 0.3448 
FMIA 1.32 6.21 0.88 3.09 -0.44 50 1.51 0.1385 
OP to FH angle 1.32 3.95 0.56 2.44 0.20 50 2.37 0.0219 
U1 to SeNa angle -4.51 10.02 1.42 -1.66 -7.36 50 -3.18 0.0025 
Interincisal angle 5.57 12.72 1.80 9.18 1.95 50 3.09 0.0033 
U1 to Na A Pt angle -2.74 9.54 1.35 -0.03 -5.46 50 -2.03 0.0474 
U1 to Na A Pt mm -1.77 3.15 0.45 -0.88 -2.67 50 -3.99 0.0002 
L1 to A Pg mm -0.39 2.42 0.34 0.30 -1.08 50 -1.13 0.2625 
L1 to A Pg angle 2.13 6.67 0.94 4.02 0.23 50 2.26 0.0285 
L1 to Na B Pt angle -1.05 6.28 0.89 0.73 -2.84 50 -1.19 0.2410 
L1 to Na B Pt mm -0.84 2.54 0.36 -0.12 -1.56 50 -2.33 0.0238 
Facial angle 0.92 2.01 0.28 1.49 0.35 50 3.23 0.0022 
Mand Length 5.78 6.14 0.87 7.52 4.03 50 6.65 <0.0001 
Sella-to-A Point 1.22 4.40 0.62 2.47 -0.03 50 1.96 0.0562 
Sella-to-B Point 3.69 5.54 0.78 5.26 2.12 50 4.71 <0.0001 
Overbite -1.82 2.42 0.34 -1.13 -2.51 50 -5.32 <0.0001 
Overjet -3.44 2.76 0.39 -2.66 -4.23 50 -8.82 <0.0001 
A Pt to Na-Perp -1.78 2.44 0.34 -1.09 -2.48 50 -5.17 <0.0001 
B Pt to Na-Perp -0.19 3.49 0.49 0.80 -1.18 50 -0.38 0.7048 
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APPENDIX B 
CEPHALOMETRIC TRACINGS 
 
Prints of the cephalometric tracings (superimpositions) of the subjects 
used in the present study.  For the Bionator-treated group, the black lines are at 
pretreatment, the green lines are at the beginning of fixed appliances, and the 
red lines are at the end of treatment.  For the Edgewise cases, the black lines are 
at the start of treatment, and the red lines are at the end of treatment.  Each 
superimposition is followed by its matched counterpart superimposition.  All 
tracings are printed at true size (i.e., 1:1 with the original radiograph).
 
 
Figure B-1.  Print of cephalometric tracing superimposition subject 01: (tracing 
is 1:1 with original radiograph). 
 194 
 
 
Figure B-2.  Print of cephalometric tracing superimposition subject 02: (tracing 
is 1:1 with original radiograph). 
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Figure B-3.  Print of cephalometric tracing superimposition subject 03: (tracing 
is 1:1 with original radiograph). 
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Figure B-4.  Print of cephalometric tracing superimposition subject 04: (tracing 
is 1:1 with original radiograph). 
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Figure B-5.  Print of cephalometric tracing superimposition subject 05: (tracing 
is 1:1 with original radiograph). 
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Figure B-6.  Print of cephalometric tracing superimposition subject 06: (tracing 
is 1:1 with original radiograph). 
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Figure B-7.  Print of cephalometric tracing superimposition subject 07: (tracing 
is 1:1 with original radiograph). 
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Figure B-8.  Print of cephalometric tracing superimposition subject 08: (tracing 
is 1:1 with original radiograph). 
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Figure B-9.  Print of cephalometric tracing superimposition subject 09: (tracing 
is 1:1 with original radiograph). 
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Figure B-10.  Print of cephalometric tracing superimposition subject 10: (tracing 
is 1:1 with original radiograph). 
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Figure B-11.  Print of cephalometric tracing superimposition subject 11: (tracing 
is 1:1 with original radiograph). 
 204 
 
 
Figure B-12.  Print of cephalometric tracing superimposition subject 12: (tracing 
is 1:1 with original radiograph). 
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Figure B-13.  Print of cephalometric tracing superimposition subject 13: (tracing 
is 1:1 with original radiograph). 
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Figure B-14.  Print of cephalometric tracing superimposition subject 14: (tracing 
is 1:1 with original radiograph). 
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Figure B-15.  Print of cephalometric tracing superimposition subject 15: (tracing 
is 1:1 with original radiograph). 
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Figure B-16.  Print of cephalometric tracing superimposition subject 16: (tracing 
is 1:1 with original radiograph). 
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Figure B-17.  Print of cephalometric tracing superimposition subject 17: (tracing 
is 1:1 with original radiograph). 
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Figure B-18.  Print of cephalometric tracing superimposition subject 18: (tracing 
is 1:1 with original radiograph). 
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Figure B-19.  Print of cephalometric tracing superimposition subject 19: (tracing 
is 1:1 with original radiograph). 
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Figure B-20.  Print of cephalometric tracing superimposition subject 20: (tracing 
is 1:1 with original radiograph). 
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Figure B-21.  Print of cephalometric tracing superimposition subject 21: (tracing 
is 1:1 with original radiograph). 
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Figure B-22.  Print of cephalometric tracing superimposition subject 22: (tracing 
is 1:1 with original radiograph). 
 215 
 
 
Figure B-23.  Print of cephalometric tracing superimposition subject 23: (tracing 
is 1:1 with original radiograph). 
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Figure B-24.  Print of cephalometric tracing superimposition subject 24: (tracing 
is 1:1 with original radiograph). 
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Figure B-25.  Print of cephalometric tracing superimposition subject 25: (tracing 
is 1:1 with original radiograph). 
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Figure B-26.  Print of cephalometric tracing superimposition subject 26: (tracing 
is 1:1 with original radiograph). 
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Figure B-27.  Print of cephalometric tracing superimposition subject 27: (tracing 
is 1:1 with original radiograph). 
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Figure B-28.  Print of cephalometric tracing superimposition subject 28: (tracing 
is 1:1 with original radiograph). 
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Figure B-29.  Print of cephalometric tracing superimposition subject 29: (tracing 
is 1:1 with original radiograph). 
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Figure B-30.  Print of cephalometric tracing superimposition subject 30: (tracing 
is 1:1 with original radiograph). 
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Figure B-31.  Print of cephalometric tracing superimposition subject 31: (tracing 
is 1:1 with original radiograph). 
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Figure B-32.  Print of cephalometric tracing superimposition subject 32: (tracing 
is 1:1 with original radiograph). 
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Figure B-33.  Print of cephalometric tracing superimposition subject 33: (tracing 
is 1:1 with original radiograph). 
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Figure B-34.  Print of cephalometric tracing superimposition subject 34: (tracing 
is 1:1 with original radiograph). 
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Figure B-35.  Print of cephalometric tracing superimposition subject 35: (tracing 
is 1:1 with original radiograph). 
 228 
 
 
Figure B-36.  Print of cephalometric tracing superimposition subject 36: (tracing 
is 1:1 with original radiograph). 
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Figure B-37.  Print of cephalometric tracing superimposition subject 37: (tracing 
is 1:1 with original radiograph). 
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Figure B-38.  Print of cephalometric tracing superimposition subject 38: (tracing 
is 1:1 with original radiograph). 
 231 
 
 
Figure B-39.  Print of cephalometric tracing superimposition subject 39: (tracing 
is 1:1 with original radiograph). 
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Figure B-40.  Print of cephalometric tracing superimposition subject 40: (tracing 
is 1:1 with original radiograph). 
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Figure B-41.  Print of cephalometric tracing superimposition subject 41: (tracing 
is 1:1 with original radiograph). 
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Figure B-42.  Print of cephalometric tracing superimposition subject 42: (tracing 
is 1:1 with original radiograph). 
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Figure B-43.  Print of cephalometric tracing superimposition subject 43: (tracing 
is 1:1 with original radiograph). 
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Figure B-44.  Print of cephalometric tracing superimposition subject 44: (tracing 
is 1:1 with original radiograph). 
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Figure B-45.  Print of cephalometric tracing superimposition subject 45: (tracing 
is 1:1 with original radiograph). 
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Figure B-46.  Print of cephalometric tracing superimposition subject 46: (tracing 
is 1:1 with original radiograph). 
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Figure B-47.  Print of cephalometric tracing superimposition subject 47: (tracing 
is 1:1 with original radiograph). 
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Figure B-48.  Print of cephalometric tracing superimposition subject 48: (tracing 
is 1:1 with original radiograph). 
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Figure B-49.  Print of cephalometric tracing superimposition subject 49: (tracing 
is 1:1 with original radiograph). 
 242 
 
 
Figure B-50.  Print of cephalometric tracing superimposition subject 50: (tracing 
is 1:1 with original radiograph). 
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Figure B-51.  Print of cephalometric tracing superimposition subject 51: (tracing 
is 1:1 with original radiograph). 
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Figure B-52.  Print of cephalometric tracing superimposition subject 52: (tracing 
is 1:1 with original radiograph). 
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Figure B-53.  Print of cephalometric tracing superimposition subject 53: (tracing 
is 1:1 with original radiograph). 
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Figure B-54.  Print of cephalometric tracing superimposition subject 54: (tracing 
is 1:1 with original radiograph). 
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Figure B-55.  Print of cephalometric tracing superimposition subject 55: (tracing 
is 1:1 with original radiograph). 
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Figure B-56.  Print of cephalometric tracing superimposition subject 56: (tracing 
is 1:1 with original radiograph). 
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Figure B-57.  Print of cephalometric tracing superimposition subject 57: (tracing 
is 1:1 with original radiograph). 
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Figure B-58.  Print of cephalometric tracing superimposition subject 58: (tracing 
is 1:1 with original radiograph). 
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Figure B-59.  Print of cephalometric tracing superimposition subject 59: (tracing 
is 1:1 with original radiograph). 
 252 
 
 
Figure B-60.  Print of cephalometric tracing superimposition subject 60: (tracing 
is 1:1 with original radiograph). 
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Figure B-61.  Print of cephalometric tracing superimposition subject 61: (tracing 
is 1:1 with original radiograph). 
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Figure B-62.  Print of cephalometric tracing superimposition subject 62: (tracing 
is 1:1 with original radiograph). 
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Figure B-63.  Print of cephalometric tracing superimposition subject 63: (tracing 
is 1:1 with original radiograph). 
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Figure B-64.  Print of cephalometric tracing superimposition subject 64: (tracing 
is 1:1 with original radiograph). 
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Figure B-65.  Print of cephalometric tracing superimposition subject 65: (tracing 
is 1:1 with original radiograph). 
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Figure B-66.  Print of cephalometric tracing superimposition subject 66: (tracing 
is 1:1 with original radiograph). 
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Figure B-67.  Print of cephalometric tracing superimposition subject 67: (tracing 
is 1:1 with original radiograph). 
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Figure B-68.  Print of cephalometric tracing superimposition subject 68: (tracing 
is 1:1 with original radiograph). 
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Figure B-69.  Print of cephalometric tracing superimposition subject 69: (tracing 
is 1:1 with original radiograph). 
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Figure B-70.  Print of cephalometric tracing superimposition subject 70: (tracing 
is 1:1 with original radiograph). 
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Figure B-71.  Print of cephalometric tracing superimposition subject 71: (tracing 
is 1:1 with original radiograph). 
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Figure B-72.  Print of cephalometric tracing superimposition subject 72: (tracing 
is 1:1 with original radiograph). 
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Figure B-73.  Print of cephalometric tracing superimposition subject 73: (tracing 
is 1:1 with original radiograph). 
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Figure B-74.  Print of cephalometric tracing superimposition subject 74: (tracing 
is 1:1 with original radiograph). 
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Figure B-75.  Print of cephalometric tracing superimposition subject 75: (tracing 
is 1:1 with original radiograph). 
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Figure B-76.  Print of cephalometric tracing superimposition subject 76: (tracing 
is 1:1 with original radiograph). 
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Figure B-77.  Print of cephalometric tracing superimposition subject 77: (tracing 
is 1:1 with original radiograph). 
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Figure B-78.  Print of cephalometric tracing superimposition subject 78: (tracing 
is 1:1 with original radiograph). 
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Figure B-79.  Print of cephalometric tracing superimposition subject 79: (tracing 
is 1:1 with original radiograph). 
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Figure B-80.  Print of cephalometric tracing superimposition subject 80: (tracing 
is 1:1 with original radiograph). 
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Figure B-81.  Print of cephalometric tracing superimposition subject 81: (tracing 
is 1:1 with original radiograph). 
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Figure B-82.  Print of cephalometric tracing superimposition subject 82: (tracing 
is 1:1 with original radiograph). 
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Figure B-83.  Print of cephalometric tracing superimposition subject 83: (tracing 
is 1:1 with original radiograph). 
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Figure B-84.  Print of cephalometric tracing superimposition subject 84: (tracing 
is 1:1 with original radiograph). 
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Figure B-85.  Print of cephalometric tracing superimposition subject 85: (tracing 
is 1:1 with original radiograph). 
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Figure B-86.  Print of cephalometric tracing superimposition subject 86: (tracing 
is 1:1 with original radiograph). 
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Figure B-87.  Print of cephalometric tracing superimposition subject 87: (tracing 
is 1:1 with original radiograph). 
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Figure B-88.  Print of cephalometric tracing superimposition subject 88: (tracing 
is 1:1 with original radiograph). 
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Figure B-89.  Print of cephalometric tracing superimposition subject 89: (tracing 
is 1:1 with original radiograph). 
 282 
 
 
Figure B-90.  Print of cephalometric tracing superimposition subject 90: (tracing 
is 1:1 with original radiograph). 
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Figure B-91.  Print of cephalometric tracing superimposition subject 91: (tracing 
is 1:1 with original radiograph). 
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Figure B-92.  Print of cephalometric tracing superimposition subject 92: (tracing 
is 1:1 with original radiograph). 
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Figure B-93.  Print of cephalometric tracing superimposition subject 93: (tracing 
is 1:1 with original radiograph). 
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Figure B-94.  Print of cephalometric tracing superimposition subject 94: (tracing 
is 1:1 with original radiograph). 
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Figure B-95.  Print of cephalometric tracing superimposition subject 95 (tracing 
is 1:1 with original radiograph). 
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Figure B-96.  Print of cephalometric tracing superimposition subject 96: (tracing 
is 1:1 with original radiograph). 
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Figure B-97.  Print of cephalometric tracing superimposition subject 97: (tracing 
is 1:1 with original radiograph). 
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Figure B-98.  Print of cephalometric tracing superimposition subject 98: (tracing 
is 1:1 with original radiograph). 
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Figure B-99.  Print of cephalometric tracing superimposition subject 99: (tracing 
is 1:1 with original radiograph). 
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Figure B-100.  Print of cephalometric tracing superimposition subject 100: 
(tracing is 1:1 with original radiograph). 
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